MIRA INFORM REPORT

Report Date :

11.11.2013

IDENTIFICATION DETAILS

Name :	ATMI INC
Registered Office :	7 Commerce Drive Danbury, CT 06810
Country :	United States
Financials (as on) :	31.12.2012
Date of Incorporation :	09.04.1997
Legal Form :	Public Parent
Line of Business :	· Supplier of materials, materials packaging and materials delivery systems · Manufacture of microelectronics devices
No. of Employees :	817

RATING & COMMENTS

MIRA’s Rating :

Ba

RATING		STATUS	PROPOSED CREDIT LINE
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory

Status :	Satisfactory
Payment Behaviour :	No complaints
Litigation :	Clear

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

ECGC Country Risk Classification List – March 31^st, 2013

Country Name	Previous Rating (31.12.2012)	Current Rating (31.03.2013)
United States	A1	A1

Risk Category	ECGC Classification
Insignificant	A1
Low	A2
Moderate	B1
High	B2
Very High	C1
Restricted	C2
Off-credit	D

UNITED STATES - ECONOMIC OVERVIEW

The US has the largest and most technologically powerful economy in the world, with a per capita GDP of $49,800. In this market-oriented economy, private individuals and business firms make most of the decisions, and the federal and state governments buy needed goods and services predominantly in the private marketplace. US business firms enjoy greater flexibility than their counterparts in Western Europe and Japan in decisions to expand capital plant, to lay off surplus workers, and to develop new products. At the same time, they face higher barriers to enter their rivals' home markets than foreign firms face entering US markets. US firms are at or near the forefront in technological advances, especially in computers and in medical, aerospace, and military equipment; their advantage has narrowed since the end of World War II. The onrush of technology largely explains the gradual development of a "two-tier labor market" in which those at the bottom lack the education and the professional/technical skills of those at the top and, more and more, fail to get comparable pay raises, health insurance coverage, and other benefits. Since 1975, practically all the gains in household income have gone to the top 20% of households. Since 1996, dividends and capital gains have grown faster than wages or any other category of after-tax income. Imported oil accounts for nearly 55% of US consumption. Crude oil prices doubled between 2001 and 2006, the year home prices peaked; higher gasoline prices ate into consumers' budgets and many individuals fell behind in their mortgage payments. Oil prices climbed another 50% between 2006 and 2008, and bank foreclosures more than doubled in the same period. Besides dampening the housing market, soaring oil prices caused a drop in the value of the dollar and a deterioration in the US merchandise trade deficit, which peaked at $840 billion in 2008. The sub-prime mortgage crisis, falling home prices, investment bank failures, tight credit, and the global economic downturn pushed the United States into a recession by mid-2008. GDP contracted until the third quarter of 2009, making this the deepest and longest downturn since the Great Depression. To help stabilize financial markets, in October 2008 the US Congress established a $700 billion Troubled Asset Relief Program (TARP). The government used some of these funds to purchase equity in US banks and industrial corporations, much of which had been returned to the government by early 2011. In January 2009 the US Congress passed and President Barack OBAMA signed a bill providing an additional $787 billion fiscal stimulus to be used over 10 years - two-thirds on additional spending and one-third on tax cuts - to create jobs and to help the economy recover. In 2010 and 2011, the federal budget deficit reached nearly 9% of GDP. In 2012 the federal government reduced the growth of spending and the deficit shrank to 7.6% of GDP. Wars in Iraq and Afghanistan required major shifts in national resources from civilian to military purposes and contributed to the growth of the budget deficit and public debt. Through 2011, the direct costs of the wars totaled nearly $900 billion, according to US government figures. US revenues from taxes and other sources are lower, as a percentage of GDP, than those of most other countries. In March 2010, President OBAMA signed into law the Patient Protection and Affordable Care Act, a health insurance reform that will extend coverage to an additional 32 million American citizens by 2016, through private health insurance for the general population and Medicaid for the impoverished. Total spending on health care - public plus private - rose from 9.0% of GDP in 1980 to 17.9% in 2010. In July 2010, the president signed the DODD-FRANK Wall Street Reform and Consumer Protection Act, a law designed to promote financial stability by protecting consumers from financial abuses, ending taxpayer bailouts of financial firms, dealing with troubled banks that are "too big to fail," and improving accountability and transparency in the financial system - in particular, by requiring certain financial derivatives to be traded in markets that are subject to government regulation and oversight. In December 2012, the Federal Reserve Board announced plans to purchase $85 billion per month of mortgage-backed and Treasury securities in an effort to hold down long-term interest rates, and to keep short term rates near zero until unemployment drops to 6.5% from the December rate of 7.8%, or until inflation rises above 2.5%. Long-term problems include stagnation of wages for lower-income families, inadequate investment in deteriorating infrastructure, rapidly rising medical and pension costs of an aging population, energy shortages, and sizable current account and budget deficits - including significant budget shortages for state governments

Source : CIA

Company name and address

ATMI INC

7 Commerce Drive
Danbury, CT 06810
United States
Map
Tel:	203-794-1100
Fax:	203-794-1100
Toll Free:	(800) 766-2681

Employees:

817

Company Type:

Public Parent

Corporate Family:

15 Companies

Traded:

NASDAQ:

ATMI

Incorporation Date:

07-Apr-1997

Auditor:

Ernst & Young LLP

Credit Rating:

A+ (100)

Fiscal Year End:	31-Dec-2012
Reporting Currency:	US Dollar
Annual Sales:	407.4 ^1
Net Income:	42.3
Total Assets:	599.2 ^2
Market Value:	893.9
	(18-Oct-2013)

Business Description

ATMI, Inc. (ATMI) is a supplier of materials, materials packaging and materials delivery systems used globally in the manufacture of microelectronics devices. The Company’s products consist of front-end semiconductor performance materials, sub-atmospheric pressure gas delivery systems for safe handling and delivery of toxic and hazardous gases to semiconductor process equipment, and materials packaging and dispensing systems. ATMI’s customers include semiconductor manufacturers in the world who target technologies. ATMI’s semiconductor business tracks semiconductor wafer starts. For the six months ended 30 June 2013, ATMI Inc revenues increased 1% to $201.4M. Net income increased 17% to $17.9M. Revenues reflect Microelectronics segment increase of 88% to $177.5M, Life Sciences segment increase from $11.2M to $23.2M, Corporate/Other segment increase from $227K to $665K. Net income benefited from Microelectronics segment income increase of 72% to $52.2M.

Industry

Industry	Semiconductor and Other Electronic Component Manufacturing
ANZSIC 2006:	2429 - Other Electronic Equipment Manufacturing
ISIC Rev 4:	2610 - Manufacture of electronic components and boards
NACE Rev 2:	2611 - Manufacture of electronic components
NAICS 2012:	334413 - Semiconductor and Related Device Manufacturing
UK SIC 2007:	2611 - Manufacture of electronic components
US SIC 1987:	3674 - Semiconductors and Related Devices

Key Executives   (Emails Available)

Name	Title
Douglas A. Neugold	Chairman of the Board, President, Chief Executive Officer
Timothy C. Carlson	Chief Financial Officer, Executive Vice President, Treasurer
Daniel P. Sharkey	Executive Vice President - Business Development
Paul J. Hohlstein	Senior Vice President - Supply Chain and Operations
Lawrence H. Dubois	Senior Vice President, Chief Technology Officer

Significant Developments

Topic	#*	Most Recent Headline	Date
Strategic Combinations	1	ATMI Inc And Finesse Solutions, Inc Sign Distribution Agreement For Turnkey Bioreactor Systems	16-Apr-2013

News

Title	Date
Orgenesis Establishes Belgium Subsidiary for Manufacturing Process Development of Clinical Grade Cel Yahoo! Finance (623 Words)	5-Nov-2013
Orgenesis Establishes Belgium Subsidiary for Manufacturing Process Development of Clinical Grade Cel Marketwired Yahoo! Finance (623 Words)	5-Nov-2013
Orgenesis Establishes Belgium Subsidiary for Manufacturing Process Development of Clinical Grade Cel Yahoo! Finance (623 Words)	5-Nov-2013
Orgenesis Establishes Belgium Subsidiary for Manufacturing Process Development of Clinical Grade Cells Market Wire (801 Words)	5-Nov-2013
Bioreactor probe connection system U.S. Patents (174 Words)	4-Nov-2013
NeoStem, Inc. Subsidiary Progenitor Cell Therapy Announces Cell Therapy Manufacturing Collaboration With ATMI BioSpace (71 Words)	4-Nov-2013

Financial Summary

As of 30-Jun-2013

Key Ratios	Company	Industry
Current Ratio (MRQ)	5.29	3.90
Quick Ratio (MRQ)	3.72	3.02
Debt to Equity (MRQ)	0.0000	0.21
Sales 5 Year Growth	2.28	11.04
Net Profit Margin (TTM) %	10.95	19.30
Return on Assets (TTM) %	7.94	15.21
Return on Equity (TTM) %	9.18	21.72

Stock Snapshot

Traded: NASDAQ: ATMI

As of 18-Oct-2013

   Financials in: USD

Recent Price	28.02	EPS	1.33
52 Week High	28.41	Price/Sales	2.19
52 Week Low	17.59	Price/Earnings	16.81
Avg. Volume (mil)	0.13	Price/Book	1.77
Market Value (mil)	893.88	Beta	1.25

	Price % Change	Rel S&P 500%
4 Week	4.59%	2.52%
13 Week	3.39%	0.28%
52 Week	52.28%	27.22%
Year to Date	34.20%	9.71%

ABI Number: 477537682

1 - Profit & Loss Item Exchange Rate: USD 1 = USD 1

2 - Balance Sheet Item Exchange Rate: USD 1 = USD 1

Corporate Overview

ATMI Inc

Location
7 Commerce Drive
Danbury, CT, 06810
Fairfield County
United States

Tel:	203-794-1100
Fax:	203-794-1100
Toll Free Tel:	(800) 766-2681

www.atmi.com

Quote Symbol - Exchange
ATMI - NASDAQ
Sales USD(mil):	407.4
Assets USD(mil):	599.2
Employees:	817
Fiscal Year End:	31-Dec-2012

Industry:

Semiconductors

Incorporation Date:	07-Apr-1997
Company Type:	Public Parent
Quoted Status:	Quoted

Chairman of the Board, President, Chief Executive Officer:

Douglas A. Neugold

Industry Codes

ANZSIC 2006 Codes:
2429	-	Other Electronic Equipment Manufacturing
2499	-	Other Machinery and Equipment Manufacturing Not Elsewhere Classified
2412	-	Medical and Surgical Equipment Manufacturing

ISIC Rev 4 Codes:
2610	-	Manufacture of electronic components and boards
3250	-	Manufacture of medical and dental instruments and supplies
2819	-	Manufacture of other general-purpose machinery

NACE Rev 2 Codes:
2611	-	Manufacture of electronic components
3250	-	Manufacture of medical and dental instruments and supplies
2829	-	Manufacture of other general-purpose machinery n.e.c.

NAICS 2012 Codes:
334413	-	Semiconductor and Related Device Manufacturing
339113	-	Surgical Appliance and Supplies Manufacturing
334510	-	Electromedical and Electrotherapeutic Apparatus Manufacturing
333999	-	All Other Miscellaneous General Purpose Machinery Manufacturing

US SIC 1987:
3674	-	Semiconductors and Related Devices
3842	-	Orthopedic, Prosthetic, and Surgical Appliances and Supplies
3569	-	General Industrial Machinery and Equipment, Not Elsewhere Classified
3845	-	Electromedical and Electrotherapeutic Apparatus

UK SIC 2007:
2611	-	Manufacture of electronic components
3250	-	Manufacture of medical and dental instruments and supplies
2829	-	Manufacture of other general-purpose machinery n.e.c.

Business Description

ATMI, Inc. (ATMI), incorporated in 1997, is a supplier of materials, materials packaging and materials delivery systems used globally in the manufacture of microelectronics devices. The Company’s products consist of front-end semiconductor performance materials, sub-atmospheric pressure gas delivery systems for safe handling and delivery of toxic and hazardous gases to semiconductor process equipment, and materials packaging and dispensing systems. ATMI’s customers include semiconductor manufacturers in the world who target technologies. ATMI’s semiconductor business tracks semiconductor wafer starts.

Microelectronics Products and Processes

Products serving the integrated circuit (IC) fabrication market represent the largest portion of ATMI’s business and development activities. ATMI’s SDS solutions use a gas cylinder containing an adsorbent material. The cylinder is filled with gas under conditions, such that the gas is adsorbed onto the adsorbent material at sub-atmospheric pressure. ATMI’s SDS solutions use a gas cylinder containing an adsorbent material. In addition, SDS products allow more process gas to be stored in the cylinder. Materials packaged in SDS systems include primarily arsine, phosphine, and boron trifluoride. The third generation of SDS products, called SDS3, maintains all the inherent safety features of previous generation SDS products, but increases the gas storage capacity by using a new adsorbent.

The Company’s copper electroplating materials and processes in semiconductor development and manufacturing with its Viaform product, include inorganic and organic molecules that provide the wiring for copper interconnects allowing manufacturers to eliminate processing steps. ATMI also focuses on the total copper integration scheme with post-chemical mechanical planarization (CMP) cleaning solutions developed using its high-productivity development (HPD) capability.

The processes for depositing thin films, such as chemical vapor deposition (CVD) and atomic layer deposition (ALD) processes that are enabled by advanced liquid, gaseous and solid precursors. ATMI markets its UltraPur materials for pre-metal dielectric, dielectric and barrier applications. ATMI forms ProE-Vap ampoule. This container allows for reliable delivery of solid precursors required for processes. ATMI has adopted the carbon adsorption technology used in sodium dodecyl sulfate (SDS) and products for semiconductor deposition processes marketed under the SAGE brand. These applications include: low-k plasma-enhanced deposition (PE-CVD), processes using low-k materials, pre-metal dielectric high-density plasma (HDP-CVD), and films using phosphine gases and thermal deposition processes using germane gases. ATMI’s ST and AP photoresist strip cleaning materials are chemistries used for applications such as semiconductor post-etch residue removal, wafer etching, organics removal, negative resist removal, edge bead removal, and corrosion prevention.

ATMI’s NOWPak liner technologies and container assemblies form the basis for its liquid materials packaging and dispensing system product portfolio for applications in IC fabrication and flat-panel display. This product line includes the Bag-in-a-Bottle and Bag-in-a-Can container systems which have their own companion dispense connection systems. Each package features a pre-cleaned collapsible inner liner, or bag, inside a rugged, high-density polyethylene overpack. The standard liner films are made of polytetrafluoroethylene and other polymers, which allow chemicals to be delivered to the manufacturing process.

Life Sciences Products

ATMI is addressing a range of critical materials handling needs for the life sciences markets. Other markets for its purity materials handling and dispensing systems include the biotechnology, laboratory and cell therapy markets. The solutions delivered to its customers consist of a hardware system, which is compatible with a one-time use mixing bag container; the technology delivers particle-free mixing and is scalable to an industrial scale. ATMI mixing technology is used for preparing buffers and media solutions for feeding the cell culture and chromatography applications, but also other process steps like virus inactivation and final-fill solutions.

The Company competes with Air Products and Chemicals, DuPont Electronic Technologies, Dow Chemical Company, BASF, Air Liquide, Praxair, Inc., Sartorius Stedim Biotech S.A., Thermo Scientific HyClone, Merck Millipore, and Xcellerex

More Business Descriptions

ATMI, Inc. (ATMI) is a supplier of materials, materials packaging and materials delivery systems used globally in the manufacture of microelectronics devices. The Company’s products consist of front-end semiconductor performance materials, sub-atmospheric pressure gas delivery systems for safe handling and delivery of toxic and hazardous gases to semiconductor process equipment, and materials packaging and dispensing systems. ATMI’s customers include semiconductor manufacturers in the world who target technologies. ATMI’s semiconductor business tracks semiconductor wafer starts. For the six months ended 30 June 2013, ATMI Inc revenues increased 1% to $201.4M. Net income increased 17% to $17.9M. Revenues reflect Microelectronics segment increase of 88% to $177.5M, Life Sciences segment increase from $11.2M to $23.2M, Corporate/Other segment increase from $227K to $665K. Net income benefited from Microelectronics segment income increase of 72% to $52.2M.

Semiconductor Materials & Packaging Products Mfr

Establishments primarily engaged in the wholesale distribution of electrical power equipment for the generation, transmission, distribution, or control of electric energy; electrical construction materials for outside power transmission lines and for electrical systems; and electric light fixtures and bulbs.

ATMI, Inc. (ATMI) supplies high performance materials, materials packaging, and materials delivery systems used in the manufacture of microelectronics devices around the world. In addition, the company offers applications and analytical support services associated with each of its product categories. It offers its products and services to three principal markets such as IC fabrication, flat-panel displays, and life sciences. ATMI operates its business through two reportable operating segments, namely, Microelectronics and LifeSciences.The company’s Microelectronics business unit sells high-purity materials and materials delivery systems directly to integrated circuit manufacturers and to chemical suppliers for flat-panel display manufacturing. Its Microelectronics products include ATMI’s patented Safe Delivery Source® (“SDS�) solutions, copper integration and surface preparation products, deposition materials and high-purity liquid materials packaging solutions. For the fiscal year ended 2012, ATMI’s Microelectronics segment reported revenue of USD 365.5m, reflecting an increase of 4% over revenue in the year 2011. The segment contributed 89.71% to the company’s total revenue in 2012. Its LifeSciences business unit sells products that address an increasing number of critical process steps for the biotechnology, laboratory and cell therapy markets, including disposable mixers and bioreactors. This unit includes its Newform products and Integrity mixers, bioreactors and bioprocess vessels. For the fiscal year ended 2012, ATMI’s LifeSciences segment reported revenue of USD 41.93m, reflecting an increase of 8.7% over revenue in the year 2011. The segment contributed 10.29% to the company’s total revenue in 2012.It manufactures its products at its manufacturing facilities located across the world. ATMI has five manufacturing facilities across the US, Asia Pacific, and Europe. The facility located at Anseong (South Korea) manufactures liquid materials, while the one located in Hoegaarden (Belgium) is into manufacturing high-purity materials packaging and mixing systems. The facilities located in Burnet (Texas, US), Bloomington (Minnesota, US), and Danbury (Connecticut, US) manufacture liquid materials and delivery systems, high-purity materials packaging systems, and gas delivery systems and liquid materials respectively. The company has a contract manufacturer which manufactures and distributes its SDS products.Its research and development (R&D) activities are aimed at improving existing products and also introducing new products. As part of its R&D efforts, ATMI takes part in joint development programs with semiconductor manufacturers, advanced technology developers, and original equipment manufacturers (OEMs). The company has alliances with Matheson Tri-Gas, Inc. (Matheson) and Enthone, Inc. (Enthone), a subsidiary of Cookson Electronics. A significant number of its strategic alliances are with semiconductor manufacturers or OEMs, which help improve its core technology base. ATMI‘s R&D expenses for the fiscal year 2012 represented 13.5% of the total revenue of the company.The company sells and distributes its products using a direct global sales and service organization. Its products are marketed and sold to end-use customers, chemical suppliers, and OEMs with the help of its direct sales channel in North America, Europe, Taiwan, South Korea, Japan, China, and Singapore. The life sciences materials handling products offered by ATMI are sold directly to semiconductor and life sciences companies. Also, the company’s SDS products for ion implant applications are sold through Matheson Tri-Gas, Inc. (Matheson), with which ATMI has a distribution agreement.Its key subsidiaries include AATMI Ecosys Corporation, Advanced Delivery & Chemical Systems Nevada, Inc., Advanced Delivery & Chemical Systems Holdings, LLC, ATMI Materials, Ltd., ATMI Korea Co., Ltd. and ATMI International Holdings, Inc., among others.Geographically, ATMI operates in seven regions, namely, the US, Taiwan, Japan, South Korea, Other Pacific Region, Belgium, and Europe and other. For the fiscal year ended December 2012, Taiwan accounted for 24.6% of the total revenue of the company followed by South Korea with 21%, the US with 19%, Japan with 11.9%, Other Pacific Region with 11.8%, Europe and Other with 10.8%, and Belgium with 0.9%.

ATMI, Inc. (ATMI) is in the business of supplying high performance materials, materials packaging, and materials delivery systems. The products and services offered by the company have wide application in the manufacture of microelectronics devices which includes front-end semiconductor performance materials, sub-atmospheric pressure gas delivery systems for safe handling and delivery of toxic and hazardous gases to semiconductor process equipment, high-purity materials packaging and dispensing systems that allow for the reliable introduction of low volatility liquids and solids to microelectronics and life sciences manufacturing processes. The target end-market of the company includes semiconductor and flat-panel display manufacturers, whose products, in turn, are used in the automotive, communication, consumer, and IT industries. ATMI caters its offerings principally to three markets, namely, IC fabrication, flat-panel displays, and life sciences. The company is headquartered in Connecticut, the US.The company reported revenues of (U.S. Dollars) USD 407.43 million during the fiscal year ended December 2012, an increase of 4.45% over 2011. The operating profit of the company was USD 59.08 million during the fiscal year 2012, whereas the company reported an operating loss of USD 38.49 million during 2011. The net profit of the company was USD 42.33 million during the fiscal year 2012, whereas the company reported a net loss of USD 20.02 million during 2011.

ATMI Inc. provides specialty semiconductor materials and high-purity materials handling and delivery solutions designed to increase process efficiencies for the worldwide semiconductor flat panel and life sciences industries.

ATMI makes materials and materials packaging for semiconductor and flat panel manufacturers around the world. It has its corporate headquarters in Danbury, Conn., and has offices and facilities throughout the United States, as well as in Asia and Europe. Established in 1986, its customers are leading chipmakers and flat panel manufacturers. The company works closely with these customers, as well as with original equipment manufacturers, to create solutions targeted to their particular needs, such as the semiconductor transition from aluminum to copper. ATMI's solutions increase yields, speed new products to market, reduce capital expenditures and costs of ownership, and mitigate risks.

Product Codes

Product Code	Product Description
AUT-AS-M	Dispensing equipment
AUT-MH-PC	Container systems
CHE-RE	Source reagents
ENV-TR-ACP	Air purification equipment
MAN-EP-A	Thin film deposition equipment
MAN-EP-A	Silicon epitaxy wafers
MAT-SV-R	Advanced materials research and development services
MAT-SV-R	Semiconductor materials research and development services
SUB-SE-H	High performance hybrid semiconductors
SUB-SE-IZ	gallium nitride semiconductors
SUB-SV-R	Semiconductor material research and development services
TAM-SC-LS	Gas scrubbers
ZZZ-HC	Holding Company

Brand/Trade Names

Cdo - Gas machinery

Financial Data

Financials in:	USD(mil)
Revenue:	407.4
Net Income:	42.3
Assets:	599.2
Long Term Debt:	0.0
Total Liabilities:	91.9
Working Capital:	0.3
Date of Financial Data:	31-Dec-2012

1 Year Growth

4.4%

NA

16.6%

Market Data

Quote Symbol:	ATMI
Exchange:	NASDAQ
Currency:	USD
Stock Price:	28.0
Stock Price Date:	10-18-2013
52 Week Price Change %:	52.3
Market Value (mil):	893,883.2
SEDOL:	2116273
ISIN:	US00207R1014
Equity and Dept Distribution:
Common Stock $.01 Par, 03/11, 100M auth., 39,833,000 issd. less 8,187,000 shs. in Treas. @ $231M. Insiders own 1.56%. IPO 11/93, 1.75M shares @ $7 by Needham & Co. PO: 3/00, 2.8M shs. (1.5M by Co.) @ $45 by Goldman.*10/97, name changed from Advanced Technology Materials.

Key Corporate Relationships

Auditor:	Ernst & Young LLP
Auditor:	Ernst & Young LLP

Additional Infomation
ABI Number:	477537682

Partnerships

, has entered into a process development (PD) agreement with ATMI, Inc.Pursuant to the PD agreement, ATMI will supply Orgenesis with a complete disposable manufacturing process for the expansion of a patient's liver cells outside of the body, an important step in enabling the company's therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes. Sav DiPasquale, CEO of Orgenesis, said, "We believe the groundbreaking Integrity® Xpansion® technology from ATMI will allow us to produce a sufficient amount of AIP (Autologous Insulin Producing) cells for transplantation back to the patient’s liver in a highly efficient and cost-effective manner. We look forward to building a successful relationship with ATMI, another very strong collaboration partner for Orgenesis as we continue to work towards initiating clinical trials of our technology." Under its integrity product line, ATMI developed the Xpansion bioreactor - a compact, fully controlled and single-use system based on stacked plates, made from the same plastic material as multiple-tray stacks. Keeping the same environment for the cells enables easy and straightforward transfer from multiple-tray stacks process to Xpansion bioreactor.

Chris Lantman, director of commercial business development at SRI Physical Sciences Division, said, "SRI International and ATMI have validated a new approach to CO2 capture. It offers significant advantages compared to current systems. SRI International believes its collaboration with ATMI will bring an important solution to the marketplace." Laboratory, pilot and field tests conducted under the direction of Gopala Krishnan, associate director of SRI International's Materials Research Laboratory, revealed that BrightBlack carbon microbead adsorbents display exceptional physical adsorption characteristics for CO2, with high capacity and low regeneration energy. They also possess better chemical and mechanical stability in an SRI International process that features a recirculating adsorbent system with integrated CO2 adsorption and steam-stripping sections.

Credit report

Location
7 Commerce Dr Danbury, CT 06810-4169 United States
County:	Fairfield
Phone:	203-794-1100
Fax:	203-792-8040
URL:	http://atmi.com
ABI^©:	477537682
Annual Sales:	$407,433,000 (USD)
Employees:	817
Facility Size(ft^2):	40,000+
Facility Own/Lease:	Lease
Business Type:	Public
Location Type:	Headquarter
Ticker:	ATMI
Exchange:	NASDAQ

Primary Line of Business:
SIC:	5063-49 - Semiconductor-Mfrs' Equip/Supls (Whls)
NAICS:	423610 - Electric Equip & Wiring Merchant Whols
Secondary Lines of Business:
NAICS:	453998 - Store Retailers Not Specified Elsewhere
	423990 - All Other Durable Goods Merchant Whols
	541613 - Marketing Consulting Svcs
	517310 - Telecommunications Resellers
SICs:	4813-02 - Telecommunications Services
	5099-01 - Exporters (Whls)
	5999-19 - Chemicals-Retail
	8742-13 - Marketing Programs & Services
	9999-66 - Federal Government Contractors
Years in InfoUSA Database:	10+

Similar Businesses in the Area *
Kulite Semiconductor Product Inc 400 Willow Tree Rd Leonia, NJ 07605-2240	Bob Most Associates 4 Hilltop Rd Mendham, NJ 07945-1244	All-Points 622 State Route 10 Ste: 19 Whippany, NJ 07981-1543
Bid Service 225 Willow Brook Rd Ste: 4 Freehold, NJ 07728-5922	Kulite Semiconductor 1040 Hoyt Ave Ridgefield, NJ 07657-1508	Valence Process Equipment 34 Columbia Rd Branchburg, NJ 08876-3519
Vishay Americas Inc 1 Greenwich Pl Shelton, CT 06484-7603	New Jersey Semi Conductor 20 Stern Ave Springfield, NJ 07081-2998	Vitesse Semiconductor Corp 488 Schooleys Mountain Rd Hackettstown, NJ 07840-4001
Cusa Reality 1913 Atlantic Ave Manasquan, NJ 08736-1029

*	Similar Businesses are defined as the closest businesses sharing the same six-digit primary SIC code ( 5063-49 - Semiconductor-Mfrs' Equip/Supls (Whls)) regardless of size.
Top

Closest Neighbors
Adam Equipment Co Limited 26 Commerce Dr Danbury, CT 06810-4131	Smiths Detection Inc 21 Commerce Dr Danbury, CT 06810-4131	Unipower LLC 3900 Coral Ridge Dr Coral Springs, FL 33065-7630
Good Directions Inc 20 Commerce Dr Danbury, CT 06810-4131	Agilent Technologies Inc 14 Commerce Dr Danbury, CT 06810-4131

Disclaimer

Credit.net, a division of infoUSA, has developed a sophisticated computer model to assign credit ratings to most of the 14 million businesses in infoUSA's database. infoUSA's proven model considers information such as the number of employees, years in business, industry stability, census data and other factors to arrive at credit ratings that are sound indicators of ability to pay. It does not factor payment histories as many big companies intentionally "slow pay".

Credit.net’s Credit Rating Scores are indicators of the probable ability to pay. We recommend that these ratings be used primarily as a starting point and should not be the sole factor used in making a credit decision. By necessity, credit decisions must be based upon the credit provider’s policies as applied to each unique transaction. You should obtain additional information from bank and trade references, local credit bureaus, or other sources before extending credit. Credit.net is not a financial advisor and makes no representations or warranties as to the accuracy, timeliness or completeness of the rating codes, and as such will not be responsible for any losses resulting from the use of this information.

The information presented in this report is a direct representation of information used in developing the credit scores and credit limits. Where information differs between Business Browser and Credit.net (e.g. executive names), the user should utilize Business Browser as their primary information source.

Corporate Structure News

Company Name	Company Type	Location	Country	Industry	Sales (USD mil)	Employees
ATMI Inc	Parent	Danbury, CT	United States	Semiconductor and Other Electronic Component Manufacturing	407.4	817
ATMI LifeSciences	Subsidiary	Hoegaarden	Belgium	Medical Equipment and Supplies		125
ATMI Packaging, Inc.	Subsidiary	Bloomington, MN	United States	Machinery and Equipment Manufacturing		100
ATMI Inc	Branch	Burnet, TX	United States	Semiconductor and Other Electronic Component Manufacturing	77.6	80
ATMI Taiwan Co. Ltd.	Subsidiary	Hsin-chu	Taiwan	Computer and Peripheral Equipment Manufacturing		60
ATMI Inc	Branch	Tempe, AZ	United States	Electronics Wholesale	64.4	50
ATMI Japan KK	Subsidiary	Tokyo	Japan	Computer and Peripheral Equipment Manufacturing		40
ATMI Korea Co. Ltd.	Subsidiary	Suwon, Gyeonggi-do	Korea, Republic of	Computer and Peripheral Equipment Manufacturing		17
ATMI PTE Ltd.	Subsidiary	Singapore	Singapore	Computer and Peripheral Equipment Manufacturing		13
ATMI Inc	Branch	Round Rock, TX	United States	Electronics Wholesale	9.6	7
ATMI GmbH	Subsidiary	Unterhaching, Bayern	Germany	Computer and Peripheral Equipment Manufacturing		5
ATMI International Holdings, Inc.	Subsidiary	Las Vegas, NV	United States	Investment Services
ATMI Taiwan Holdings, Inc.	Subsidiary	Las Vegas, NV	United States	Investment Services
ATMI International Trading Co. Ltd.	Subsidiary	Shanghai	China	Computer and Peripheral Equipment Manufacturing
ATMI Materials, Ltd.	Subsidiary	Burnet, TX	United States	Machinery and Equipment Manufacturing

Competitors Report

CompanyName	Location	Employees	Ownership
Air Liquide	Paris, France	50,000	Public
Air Products & Chemicals, Inc.	Allentown, Pennsylvania, United States	20,900	Public
BASF SE	Ludwigshafen Am Rhein, Germany	111,614	Public
Dow Chemical Co. Ltd.	Staines, United Kingdom	175	Private
E I Du Pont De Nemours And Co	Wilmington, Delaware, United States	70,000	Public
Merck KGaA	Darmstadt, Germany	38,311	Public
Praxair, Inc.	Danbury, Connecticut, United States	27,380	Public
Sartorius Stedim Biotech SA	Aubagne, France	2,994	Public
The Dow Chemical Company	Midland, Michigan, United States	52,714	Public
Xcellerex Inc	Marlborough, Massachusetts, United States	7	Private

Executives Report

Board of Directors

Name	Title	Function
Douglas A. Neugold	Chairman of the Board, President, Chief Executive Officer	Chairman
Biography: Mr. Douglas A. Neugold is Chairman of the Board, President, Chief Executive Officer of ATMI, Inc. He has served as Chairman of the Board of the Company since January 1, 2011, as Chief Executive Officer since January 1, 2005, as a Director since August 2003, and as President since May 2000. Mr. Neugold also served as Chief Operating Officer from August 2003 to 2005. Prior to his appointment as President, he served as Executive Vice President of the Materials Division from February 1999, and Vice President of the SDS gas business from January 1998. Prior to joining the Company, Mr. Neugold served in a variety of executive and managerial positions with the Electronic Materials Division of Johnson Matthey plc, a specialty chemicals company, including Vice President, and later, President, of the Semiconductor Packages business and Director of Asian Operations. Mr. Neugold also serves as the Chairman of Semiconductor Equipment and Materials International (SEMI), the trade association serving the worldwide semiconductor equipment, materials and flat panel display industries, as well as various educational boards. Mr. Neugold has semiconductor industry experience and knowledge, and has been a manager and executive in global companies for over twenty years. Age: 53 Education: Clarkson University, BS 525,000 Compensation Currency: USD
Mark A. Adley	Lead Independent Director	Director/Board Member
Biography: Mr. Mark A. Adley is Lead Independent Director of ATMI Inc. Since March 2002, Mr. Adley has been a Managing Director of Mergers & Acquisitions at Banc of America Securities LLC (now Bank of America Merrill Lynch), the investment banking subsidiary of Bank of America. From 1996 to 2001, Mr. Adley was a Managing Director at Credit Suisse First Boston Corporation, an investment banking firm. In addition to his knowledge of the Company, Mr. Adley has broad mergers and acquisitions experience and a wide-ranging background in finance and management. Age: 52
Eugene G. Banucci View Email	Independent Director	Director/Board Member
Biography: Dr. Eugene G. Banucci, Ph.D., is Independent Director of ATMI Inc. He is the founder of the Company, has served as a director since 1986, and as Chairman of the Board from 1986 through 2010. From 1986 until January 1, 2005, Dr. Banucci served as Chief Executive Officer, and as President from 1986 to April 2000. Since 2006, Dr. Banucci has served on the board of directors of Clean Harbors Corporation, a publicly-traded company in the environmental services business. From 2003 through February 2010, Dr. Banucci served on the board of directors of Zygo Corporation, a publicly-traded company that designs, develops and manufactures optical components and instruments for optics-intensive industries. As a founder of the Company, Dr. Banucci, who holds a Ph.D. in chemistry, has a comprehensive understanding of the Company and the industries it serves. Age: 69 Education: Wayne State University, PHD (Chemistry) Beloit College, BA Compensation Currency: USD Social:
Robert S. Hillas	Director	Director/Board Member
Biography: Robert Hillas has served as a director of the Company since 1987. Since January 2006 Mr. Hillas has served as Senior Advisor at Warburg Pincus LLC a private equity investing firm. From March 2005 to January 2006 Mr. Hillas was a Managing Director of Investment Banking at CIBC World Markets Corp. From April 1998 to March 2003 Mr. Hillas was the President Chief Executive Officer and Chairman of the Board of Envirogen Inc. an environmental systems and services company. Prior to April 1998 Mr. Hillas served as a Managing Director of E.M. Warburg Pincus & Co. LLC a venture banking and asset management firm. Age: 63
Stephen Herbert Mahle	Independent Director	Director/Board Member
Biography: Mr. Stephen H. Mahle is Independent Director of ATMI, Inc. Since September 2009, Mr. Mahle has been retired. From August 2007 through September 2009, Mr. Mahle served as Executive Vice President, Healthcare Policy and Regulatory, for Medtronic, Inc., a medical device manufacturer. From May 2004 to August 2007, Mr. Mahle was Executive Vice President of Medtronic and since January 1998, President of its Cardiac Rhythm Disease Management business. From 1998 to 2004, Mr. Mahle served as Senior Vice President of Medtronic. From 1995 to 1997, Mr. Mahle served as President of the Brady Pacing Business, a division of Medtronic, and prior to 1995, as Vice President and General Manager of the Brady Pacing Business. Since 2010, Mr. Mahle has served on the board of directors of EBR Systems, Inc., a privately-held company pursuing novel approaches to cardiac rhythm management. In November 2011, Mr. Mahle joined the board of Sphere Medical, Ltd., a medical device company in Cambridge, England. Mr. Mahle has broad experience as a senior executive at high-growth companies, including profit and loss responsibility for a $5 billion business and leadership of an organization of 12,000 employees. He has knowledge of the health care industry, including its regulatory framework, product quality requirements and product development issues, which are relevant to the expansion of the Company’s life sciences business. Age: 66 Education: Pennsylvania State University, M (Physics) Beloit College, BS (Physics)
C. Douglas Marsh	Independent Director	Director/Board Member
Biography: Mr. C. Douglas Marsh is Independent Director of ATMI Inc. Since April 2004, Mr. Marsh has been retired. From July 1998 to April 2004, Mr. Marsh was the Vice President, Business Integration, U.S. Investor Relations of ASML Holding NV, a seller of photolithography equipment to the semiconductor industry. Prior to July 1998, Mr. Marsh served as Vice President, Worldwide Sales and President, U.S. Operations, of ASML Holding NV. From 2001 to 2011, Mr. Marsh served on the board of directors of MEMC Electronic Materials, Inc., a publicly-traded company that produces wafers for the semiconductor and solar industries. Mr. Marsh has experience in the semiconductor business, including in the sales, marketing, general management and product development areas. Age: 66
George M. Scalise	Independent Director	Director/Board Member
Biography: Mr. George M. Scalise is Independent Director of ATMI, Inc. From 1997 to 2010, Mr. Scalise served as President of the Semiconductor Industry Association (SIA), the premier trade association representing the United States computer chip manufacturing industry on issues of trade, technology, environmental protection, and worker safety and health. Before joining SIA, Mr. Scalise was Executive Vice President and Chief Administrative Officer of Apple Computer, Inc. from 1996 to 1997. From 1991 to 1996, he served as Senior Vice President of Planning and Development and Chief Administrative Officer of National Semiconductor Corporation. Mr. Scalise served on the Board of Directors of the Federal Reserve Bank of San Francisco from 2000 to 2005, including as Chairman from 2003 to 2005. He also served on President George W. Bush’s Council of Advisors on Science and Technology from 2001 to 2009. Mr. Scalise currently serves as a director of Mindtree Ltd., a global information technology solutions company, and Cadence Design Systems, Inc., an electronic design automation software and engineering services company. In addition, Mr. Scalise serves as a director of Intermolecular, Inc. (“Intermolecular�), a company that provides high productivity combinatorial technology products and services for the semiconductor and clean energy sectors. The Company owns approximately 9% of the shares of Intermolecular, and has an ongoing commercial relationship with Intermolecular (which does not meet the threshold for disclosure under applicable regulations). Mr. Scalise recuses himself from any substantive Board of Director discussions that relate to Intermolecular. Mr. Scalise has knowledge of the semiconductor industry, as well as substantial experience as a director and senior executive of public companies in various industries. Age: 79 Education: Purdue University, BS (Mechanical Engineering)
Mark B. Segall	Board Member	Director/Board Member
Cheryl L. Shavers	Independent Director	Director/Board Member
Biography: Dr. Cheryl L. Shavers, Ph.D., is Independent Director of ATMI, Inc. Since February 2001, Dr. Shavers has been the Chief Executive Officer of Global Smarts, Inc., a corporate investment and advisory services firm. She is also a director and member of the Technology and Nominating Committees of Rockwell Collins, Inc., a publicly-traded company providing communications and aviation electronics solutions. From 1999 to 2001, Dr. Shavers served as Under Secretary of Commerce for Technology at the U.S. Department of Commerce. Prior to 1999, Dr. Shavers held a variety of senior level positions at Intel Corporation, a designer and manufacturer of integrated circuits, most recently the Director of Emerging Technologies in the Microprocessor Sector Group at Intel Capital. Dr. Shavers holds a Ph.D. in chemistry and has substantial experience in the semiconductor and other technology dependent industries with companies such as Intel, Motorola and Hewlett Packard. She is also a professor at the Leavey School of Business at Santa Clara University. Her academic and professional experiences provide a unique perspective and skill set to the Board. Age: 58 Education: Arizona State University, PHD (Chemistry) California Polytechnic State University, San Luis Obispo, M (Engineering Management) Arizona State University, B (Chemistry)

Executives

Name	Title	Function
Douglas A. Neugold	Chairman of the Board, President, Chief Executive Officer	Chief Executive Officer
Biography: Mr. Douglas A. Neugold is Chairman of the Board, President, Chief Executive Officer of ATMI, Inc. He has served as Chairman of the Board of the Company since January 1, 2011, as Chief Executive Officer since January 1, 2005, as a Director since August 2003, and as President since May 2000. Mr. Neugold also served as Chief Operating Officer from August 2003 to 2005. Prior to his appointment as President, he served as Executive Vice President of the Materials Division from February 1999, and Vice President of the SDS gas business from January 1998. Prior to joining the Company, Mr. Neugold served in a variety of executive and managerial positions with the Electronic Materials Division of Johnson Matthey plc, a specialty chemicals company, including Vice President, and later, President, of the Semiconductor Packages business and Director of Asian Operations. Mr. Neugold also serves as the Chairman of Semiconductor Equipment and Materials International (SEMI), the trade association serving the worldwide semiconductor equipment, materials and flat panel display industries, as well as various educational boards. Mr. Neugold has semiconductor industry experience and knowledge, and has been a manager and executive in global companies for over twenty years. Age: 53 Education: Clarkson University, BS Compensation/Salary:$525,000 Compensation Currency: USD
Christian Kramer	Senior Vice President & General Manager, Microelectronics Business	Division Head Executive
Biography: Mr. Christian Kramer has been appointed as Senior Vice President and General Manager - Microelectronics business of ATMI Inc. He has experience as a senior executive in the technology sector.
Mario Philips View Email	Senior Vice President and General Manager - LifeSciences	Division Head Executive
Biography: Mr. Mario Philips is Senior Vice President and General Manager - LifeSciences of ATMI Inc. Mr. Philips joined ATMI in November 1999 as part of ATMI’s acquisition of MST Analytics, Inc., serving as European Sales Manager for ATMI Analytical Systems. From October 2000 to August 2003, Mr. Philips was Global Sales and Marketing Manager for ATMI Packaging, and from August 2003 to August 2004, he was General Manager of the ATMI Packaging solids packaging business. From August 2004 to March 2010, Mr. Philips served as the General Manager of ATMI LifeSciences. Age: 42
Thomas Baum	Operations, Vice President	Senior Management (General)
Biography: Tom Baum serves as vice president of research and development. He previously worked as an advisory scientist at IBM’s Almaden Research Center. Baum has a master’s degree in chemistry from the Polytechnic Institute of New York. Education: Columbia University, master's (Real Estate Development) University of Illinois, undergraduate (Architecture) Columbia University, MS
Tom Mcgowan	Business Development, Human Resources, Senior Vice President	Senior Management (General)
Biography: Tom McGowan serves as vice president of human resources and organizational development. He previously worked as vice president of human resources for Anthem Blue Cross and USCO Logistics.
Steve Bilodeau View Email	Owner	Owner/Proprietor
Paul J. Hohlstein View Email	Senior Vice President - Supply Chain and Operations	Operations Executive
Biography: Mr. Paul J. Hohlstein is Senior Vice President - Supply Chain and Operations of ATMI, Inc. Mr. Hohlstein joined ATMI in 2005, and served as Vice President of Supply Chain and Operations, Materials, until September 2007. Prior to joining ATMI, Mr. Hohlstein was Vice President and General Manager at Pemstar, Inc., a global electronics manufacturing service provider, from 2004 through 2005. Prior to that, Mr. Hohlstein served as Vice President, Operations of the Etch Product Group at Applied Materials, Inc., a semiconductor equipment and materials provider, and also as Vice President, Global Materials and Supply Chain Management, where he was responsible for overall operations and global management, from 2000 through 2003.
Joann Blanchard	Safety Manager	Environment/Safety Executive
Matthew Donatucci View Email	Environmental Heath, Safety and Facilities	Environment/Safety Executive
Timothy C. Carlson View Email	Chief Financial Officer, Executive Vice President, Treasurer	Finance Executive
Biography: Mr. Timothy C. Carlson is Executive Vice President, Chief Financial Officer and Treasurer of ATMI, Inc. Prior to that, Mr. Carlson served as Senior Vice President and General Manager, Packaging, from March 2007 to September 2007. Previously, he was Senior Vice President, Business Development from 2005 to March 2007. Mr. Carlson joined ATMI as Vice President and Corporate Controller in 2000. Before joining ATMI, Mr. Carlson was with Campbell Soup Company, a global manufacturer of soup, beverage, confectionery and prepared food products, most recently as Finance Director for Campbell Australia and for Pepperidge Farm.
Kathie Wilson View Email	Senior Credit Analyst	Finance Executive
David M Ward	Vice President, Controller & Principal Accounting Officer	Accounting Executive
Philip Allison	Tax Analyst	Corporate Tax Executive
Sharon Roma View Email	Payroll Manager	Benefits & Compensation Executive
Kelley Demasi View Email	Human Resource Representative	Human Resources Executive
Dean Gifford View Email	Human Resources	Human Resources Executive
Kellery Karrigan View Email	Human Resources Generalist	Human Resources Executive
Teri Keels	Talent Acquisition	Human Resources Executive
Leigh Lavigne View Email	Human Resources	Human Resources Executive
Kathleen G. Mincieli View Email	Senior Vice President - Human Resources	Human Resources Executive
Biography: Ms. Kathleen G. Mincieli is Senior Vice President - Human Resources of ATMI Inc. Ms. Mincieli joined ATMI in January 2002, and served as Human Resources Manager for recruiting and performance management until January 2003. From January 2003 to November 2008, Ms. Mincieli was Senior Director of Human Resources. She then served as Vice President, Human Resources from November 2008 to January 2010. Prior to joining ATMI, Ms. Mincieli served as Director of Human Resources for USCO Logistics Services, a division of Kuehne and Nagel, one of the world’s logistics companies. Age: 57
Janel Pavlicek View Email	Human Resources Manager	Human Resources Executive
Jeannie Steele View Email	Director, Global Recruiting	Human Resources Executive
Karen Vigneux View Email	Human Resources Rep	Human Resources Executive
Stephen Curtis	Senior Vice President Sales	Sales Executive
Biography: Steve is responsible for all of ATMIs customer-facing activities and its global sales and service organization. He joined ATMI in 2007 as Director of Marketing for the Materials business. He comes to ATMI after a distinguished career at NALCO where he led the activities to educate customers and execute NALCOs highly respected value-based selling model in various industries worldwide.
Tod Higinbotham View Email	Vice President Of Sales And Marketing	Sales Executive
Biography: Tod leads ATMIs materials business throughout the world. He joined ATMI in 1999 as Vice-President of Sales and Marketing for the Epitaxial Services Division. In February of 2001 he transferred to the newly formed Material Lifecycle Solutions Division as Vice-President Sales and Service. In September 2003 the additional duties of Vice-President of Marketing were added to Tods responsibilities. He was appointed Senior Vice-President of ATMI and General Manager of the Materials division in November 2004. Before joining ATMI Tod worked for several years as Director of Sales and Marketing for Komatsus specialty silicon business unit. Prior to that he worked as a consultant leading business system reengineering projects for several high tech companies. Tod received his Bachelor of Science in Finance from Portland State University and an MBA from the University of Washington. Education: Portland State University, BS (Finance) University of Washington, MBA
Santo Scarfone View Email	Sales & Marketing Manager	Sales Executive
Jeff Craig View Email	Global Director Bd & Marketing	International Executive
Catricia Mills View Email	Global Procurement Manager	International Executive
Lou Blanchard View Email	Director of Central Marketing	Marketing Executive
Karrie Bowen View Email	Marketing Director	Marketing Executive
Robert Kaim	Director, Marketing	Marketing Executive
Dean Hamilton	Corporate Communications Executive	Corporate Communications Executive
Troy Dewar View Email	Director - Investor Relations	Investor Relations Executive
Helen Dicesare View Email	Manager, Information Technology Support	Information Executive
James Hull View Email	Systems Engineer	Information Executive
Babu Kosanam	Senior Manager of Information Technologist	Information Executive
Kevin Laing	Chief Information Officer	Information Executive
Biography: Kevin Laing serves as chief information officer. He previously worked as vice president and chief executive officer of XESystems. Laing has a master’s degree in business administration from the University of Bridgeport. Education: Southern Connecticut State University, BS (Accounting) University of Bridgeport, MBA
Jatin Mohan View Email	Manager-Information Technology	Information Executive
Frank Perugini	Information Technology Manager	Information Executive
Patrick Reid View Email	Systems Engineer	Information Executive
Ron Stahl View Email	Systems Engineer	Information Executive
Marisa Denaro View Email	Web Developer	Network Management Executive
Don Wood View Email	Network Engineer	Network Management Executive
Barry Chambers View Email	Applications Engineer	Engineering/Technical Executive
Barry Chen View Email	Engineer	Engineering/Technical Executive
Joe Despres View Email	Product Engineer	Engineering/Technical Executive
Peter Dodson View Email	Manuf Engineer	Engineering/Technical Executive
Kurt Dreesen View Email	Engineer	Engineering/Technical Executive
Lawrence H. Dubois View Email	Senior Vice President, Chief Technology Officer	Engineering/Technical Executive
Biography: Dr. Lawrence H. Dubois, Ph.D., is Senior Vice President and Chief Technology Officer of ATMI. Inc. Prior to joining ATMI, Dr. Dubois was Corporate Vice President and head of the Physical Sciences Division at SRI International from 2000 through September 2007, where he led a multidisciplinary team of over 200 scientists and engineers focusing on the development and commercialization of advanced materials and coatings, micro- and nano- fabrication technologies, power sources, medical diagnostics, molecular and optical physics, and environmentally benign processing. Prior to that, Dr. Dubois served as Director, Defense Sciences Office, at the Defense Advanced Research Project Agency (U.S. Department of Defense). He is a member of the Defense Sciences Research Council and a member of the Board of Directors of Sylvan Source, Inc. Age: 57 Education: University of California, PHD (Physical Chemistry) Massachusetts Institute of Technology, BS (Chemistry)
Russ Frye View Email	Engineer	Engineering/Technical Executive
Brian Horos View Email	Vice President of Technology	Engineering/Technical Executive
Sri Josyula View Email	Director, Enterprise Application	Engineering/Technical Executive
Shkelqim Letaj View Email	Tech Engineer	Engineering/Technical Executive
James Lin View Email	Manufacturing Engineer	Engineering/Technical Executive
Michael Mulcey View Email	Research Engineer	Engineering/Technical Executive
Abhinav Sharma View Email	Developer	Engineering/Technical Executive
Tom Wu View Email	Application Engineer	Engineering/Technical Executive
Tom Cameron View Email	Senior Scientist	Research & Development Executive
Tianniu Chen View Email	Research Scientist	Research & Development Executive
Philip Chen View Email	Scientist	Research & Development Executive
William Hunks View Email	Research Scientist	Research & Development Executive
Matt Kern View Email	Chemist	Research & Development Executive
Mackenzie King View Email	Vice President Research and Development	Research & Development Executive
Melissa Petruska View Email	Senior Scientist	Research & Development Executive
Michele Stawasz View Email	Research Scientist	Research & Development Executive
Michael Duffy View Email	Editor	Product Management Executive
Jeff Desroches View Email	Business Development Manager	Business Development Executive
John Edwards View Email	Manager, Business Analytics	Business Development Executive
Daniel P. Sharkey View Email	Executive Vice President - Business Development	Business Development Executive
Biography: Mr. Daniel P. Sharkey is Executive Vice President - Business Development of ATMI Inc. Prior to that, Mr. Sharkey served as Chief Financial Officer from 1990 to September 2007, as Treasurer from 1993 to September 2007, as Executive Vice President since 2005, and as Vice President from 1993 to 2005. Mr. Sharkey also served as Secretary from January 2004 through May 2004, and as Acting Secretary from September 2007 through January 2008. Prior to 1990, Mr. Sharkey served as Vice President of Finance and Administration for Adage, Inc., a manufacturer of high-performance computer graphics terminals, Corporate Controller for CGX Corporation, and as an Audit Supervisor for KPMG, a firm that provides audit, tax and advisory services. Age: 55 Education: the College of the Holy Cross, BA (Economics And Accounting)
Patrick J. Shima View Email	Senior Vice President, Chief Legal Officer	Legal Executive
Biography: Mr. Patrick J. Shima has been appointed as Senior Vice President, Chief Legal Officer of ATMI, Inc., with effect from September 5, 2013. Originally hired by ATMI in 2007 for the role of Transaction and Finance Counsel, Shima was later promoted to Deputy Chief Legal Officer in 2008. Since joining ATMI, Shima has had the opportunity to offer counsel on many critical ATMI business transactions. He will now provide oversight to, and be responsible for leading the company's entire legal function. Prior to joining ATMI, Shima spent six years as an attorney at IBM in positions of increasing responsibility. Before those responsibilities, he worked for Major League Soccer as Legal Counsel and as an associate at two New York law firms. Shima has a bachelor of arts in economics from Georgetown University and earned his JD from The George Washington University National Law Center. Education: George Washington University, JD Georgetown University, BA (Economics)
Shelley Decker View Email	Manager-Logistics	Logistics Executive
Joe Casanova View Email	Facilities Manager	Facilities Executive
Ron Farmer View Email	Senior Procurement Manager	Purchasing Executive
Greg Kerwick View Email	Procurement Manager	Purchasing Executive
Steve Bishop View Email	Isp Manager	Other
Preston Butler View Email	Infrastructure Manager	Other
Suraj Chakma View Email	Dw Analyst	Other
David Frare View Email	Indirect Manefacturing Manager	Other
Navneet Gill View Email	Manager	Other
Gregory Hermetet View Email	Disposable Bioreactor Specialist	Other
Rick Loofs View Email	Program Manager	Other
Alex Ospina View Email	Associate Manager	Other
Marc Panaye View Email	Vertegenwoordiger Benelux	Other
Philip Sailor View Email	Mechanical Designer Atmi	Other
Ajinkya Shirgaonkar	Program Manager Process and Solutions	Other
David Shofi	Ip Counsel	Other
Barbara Sturm View Email	Director, Manager, Department Head	Other

Significant Developments

ATMI Inc And Finesse Solutions, Inc Sign Distribution Agreement For Turnkey Bioreactor Systems

Apr 16, 2013

ATMI Inc announced the signing of a Distribution Agreement with Finesse Solutions, Inc. This agreement will allow both companies to offer customers seamless support for single-use bioreactor systems enabled by Finesse SmartSystems, and ATMI's single-use Integrity PadReactor bioreactor. The solution combines the optimized mixing and gas transfer performance of the space-efficient PadReactor system with the industry's bioreactor control platform and single-use sensors, namely, TruFluor sensors for pH and dissolved oxygen and TruTorr sensors for pressure.

Annual Income Statement

	31-Dec-2012	31-Dec-2011	31-Dec-2010	31-Dec-2009	31-Dec-2008
Period Length	12 Months	12 Months	12 Months	12 Months	12 Months
UpdateType/Date	Updated Normal 31-Dec-2012	Updated Normal 31-Dec-2011	Updated Normal 31-Dec-2010	Updated Normal 31-Dec-2009	Updated Normal 31-Dec-2008
Filed Currency	USD	USD	USD	USD	USD
Exchange Rate (Period Average)	1	1	1	1	1
Auditor	Ernst & Young LLP	Ernst & Young LLP	Ernst & Young LLP	Ernst & Young LLP	Ernst & Young LLP
Auditor Opinion	Unqualified	Unqualified	Unqualified	Unqualified	Unqualified
Net Sales	407.4	390.1	367.3	254.7	339.1
Revenue	407.4	390.1	367.3	254.7	339.1
Total Revenue	407.4	390.1	367.3	254.7	339.1
Cost of Revenue	206.5	206.0	191.2	152.5	172.6
Cost of Revenue, Total	206.5	206.0	191.2	152.5	172.6
Gross Profit	200.9	184.1	176.0	102.2	166.5
Selling/General/Administrative Expense	72.0	83.2	83.2	73.3	88.8
Labor & Related Expense	7.3	-	-	-	-
Total Selling/General/Administrative Expenses	79.3	83.2	83.2	73.3	88.8
Research & Development	46.8	53.7	48.6	37.2	37.8
Depreciation	12.4	-	-	-	-
Amortization of Intangibles	4.4	-	-	-	-
Depreciation/Amortization	16.8	-	-	-	-
Impairment-Assets Held for Use	0.0	1.1	2.2	5.0	3.4
Other Unusual Expense (Income)	1.6	84.6	0.0	0.6	-
Unusual Expense (Income)	1.6	85.7	2.2	5.6	3.4
Other, Net	-2.7	-	-	-	-
Other Operating Expenses, Total	-2.7	-	-	-	-
Total Operating Expense	348.4	428.6	325.3	268.5	302.6
Operating Income	59.1	-38.5	41.9	-13.8	36.5
Interest Expense - Non-Operating	-	-	-	0.0	-0.2
Interest Expense, Net Non-Operating	-	-	-	0.0	-0.2
Interest Income - Non-Operating	1.3	1.2	0.9	1.2	3.1
Investment Income - Non-Operating	-0.5	-	-	-	-
Interest/Investment Income - Non-Operating	0.8	1.2	0.9	1.2	3.1
Interest Income (Expense) - Net Non-Operating Total	0.8	1.2	0.9	1.2	3.0
Other Non-Operating Income (Expense)	0.3	-1.8	7.7	-1.0	0.7
Other, Net	0.3	-1.8	7.7	-1.0	0.7
Income Before Tax	60.1	-39.1	50.6	-13.7	40.1
Total Income Tax	17.8	-19.1	11.1	-7.0	6.8
Income After Tax	42.3	-20.0	39.5	-6.7	33.3
Net Income Before Extraord Items	42.3	-20.0	39.5	-6.7	33.3
Net Income	42.3	-20.0	39.5	-6.7	33.3
Income Available to Common Excl Extraord Items	42.3	-20.0	39.5	-6.7	33.3
Income Available to Common Incl Extraord Items	42.3	-20.0	39.5	-6.7	33.3
Basic/Primary Weighted Average Shares	31.9	31.7	31.4	31.4	32.1
Basic EPS Excl Extraord Items	1.33	-0.63	1.26	-0.21	1.04
Basic/Primary EPS Incl Extraord Items	1.33	-0.63	1.26	-0.21	1.04
Dilution Adjustment	-	0.0	-	0.0	-
Diluted Net Income	42.3	-20.0	39.5	-6.7	33.3
Diluted Weighted Average Shares	32.7	31.7	31.9	31.4	32.1
Diluted EPS Excl Extraord Items	1.30	-0.63	1.24	-0.21	1.04
Diluted EPS Incl Extraord Items	1.30	-0.63	1.24	-0.21	1.04
Dividends per Share - Common Stock Primary Issue	0.00	0.00	0.00	0.00	0.00
Gross Dividends - Common Stock	0.0	0.0	0.0	0.0	0.0
Interest Expense, Supplemental	-	-	-	0.0	0.2
Depreciation, Supplemental	27.6	23.3	22.8	22.3	20.1
Total Special Items	1.6	85.7	2.2	5.6	3.4
Normalized Income Before Tax	61.7	46.5	52.8	-8.1	43.6
Effect of Special Items on Income Taxes	0.5	30.0	0.5	2.0	0.6
Inc Tax Ex Impact of Sp Items	18.3	10.9	11.6	-5.0	7.4
Normalized Income After Tax	43.5	35.7	41.2	-3.0	36.2
Normalized Inc. Avail to Com.	43.5	35.7	41.2	-3.0	36.2
Basic Normalized EPS	1.36	1.12	1.31	-0.10	1.13
Diluted Normalized EPS	1.33	1.12	1.29	-0.10	1.13
Amort of Intangibles, Supplemental	4.7	3.8	4.0	4.5	4.1
Rental Expenses	3.8	3.7	3.4	4.3	3.6
Research & Development Exp, Supplemental	55.2	53.7	48.6	37.2	37.8
Normalized EBIT	60.7	47.2	44.1	-8.2	39.9
Normalized EBITDA	92.9	74.3	70.9	18.6	64.1
Current Tax - Domestic	12.7	7.3	4.1	-7.3	2.4
Current Tax - Foreign	1.7	2.7	2.3	2.2	0.8
Current Tax - Local	0.4	0.3	0.1	0.1	1.6
Current Tax - Total	14.7	10.3	6.5	-5.1	4.8
Deferred Tax - Domestic	2.6	-27.0	4.2	-0.1	3.3
Deferred Tax - Foreign	0.0	-0.3	-0.3	-1.4	-0.1
Deferred Tax - Local	0.4	-2.1	0.7	-0.4	-1.1
Deferred Tax - Total	3.0	-29.4	4.6	-1.9	2.0
Income Tax - Total	17.8	-19.1	11.1	-7.0	6.8
Defined Contribution Expense - Domestic	1.8	1.8	1.5	1.1	1.8
Total Pension Expense	1.8	1.8	1.5	1.1	1.8

Annual Balance Sheet

Financials in: USD (mil)

	31-Dec-2012	31-Dec-2011	31-Dec-2010	31-Dec-2009	31-Dec-2008
UpdateType/Date	Updated Normal 31-Dec-2012	Reclassified Normal 31-Dec-2012	Updated Normal 31-Dec-2010	Updated Normal 31-Dec-2009	Updated Normal 31-Dec-2008
Filed Currency	USD	USD	USD	USD	USD
Exchange Rate	1	1	1	1	1
Auditor	Ernst & Young LLP	Ernst & Young LLP	Ernst & Young LLP	Ernst & Young LLP	Ernst & Young LLP
Auditor Opinion	Unqualified	Unqualified	Unqualified	Unqualified	Unqualified
Cash & Equivalents	86.1	34.5	68.6	64.7	54.6
Short Term Investments	70.4	75.6	58.5	32.7	37.7
Cash and Short Term Investments	156.4	110.2	127.1	97.4	92.4
Accounts Receivable - Trade, Gross	61.7	52.3	55.3	46.5	43.2
Provision for Doubtful Accounts	-0.9	-0.8	-0.8	-2.3	-1.0
Trade Accounts Receivable - Net	60.8	51.6	54.5	44.2	42.2
Other Receivables	0.0	3.7	4.6	10.8	4.8
Total Receivables, Net	60.8	55.3	59.1	55.0	47.1
Inventories - Finished Goods	62.0	54.0	46.6	38.9	41.6
Inventories - Work In Progress	2.1	1.7	2.1	2.4	1.2
Inventories - Raw Materials	26.9	20.5	16.5	15.0	15.6
Inventories - Other	-3.4	-2.6	-2.4	-2.6	-2.4
Total Inventory	87.6	73.6	62.8	53.8	56.0
Prepaid Expenses	12.2	14.4	14.4	19.4	15.6
Deferred Income Tax - Current Asset	4.5	4.4	6.8	8.0	6.9
Other Current Assets	9.0	13.3	12.7	-	-
Other Current Assets, Total	13.5	17.7	19.5	8.0	6.9
Total Current Assets	330.5	271.2	283.0	233.6	218.0
Buildings	48.9	51.0	52.2	47.0	46.6
Land/Improvements	1.2	1.1	1.1	1.1	1.1
Machinery/Equipment	226.1	214.1	210.5	197.8	176.6
Construction in Progress	14.3	6.5	2.1	6.3	15.4
Other Property/Plant/Equipment	2.3	3.0	2.8	2.6	2.7
Property/Plant/Equipment - Gross	292.7	275.7	268.7	254.7	242.3
Accumulated Depreciation	-167.6	-159.4	-149.6	-130.1	-105.9
Property/Plant/Equipment - Net	125.1	116.3	119.1	124.6	136.4
Goodwill - Gross	46.8	46.5	47.0	33.4	33.4
Accumulated Goodwill Amortization	0.0	-	0.0	0.0	0.0
Goodwill, Net	46.8	46.5	47.0	33.4	33.4
Intangibles - Gross	77.7	62.6	51.3	47.5	47.0
Accumulated Intangible Amortization	-30.8	-26.0	-22.3	-24.3	-19.8
Intangibles, Net	46.9	36.6	28.9	23.2	27.2
LT Investments - Other	12.1	3.3	25.4	10.6	3.7
Long Term Investments	12.1	3.3	25.4	10.6	3.7
Deferred Income Tax - Long Term Asset	15.1	19.1	2.1	2.7	1.6
Other Long Term Assets	22.6	20.6	28.1	31.5	32.9
Other Long Term Assets, Total	37.7	39.8	30.2	34.2	34.5
Total Assets	599.2	513.7	533.6	459.6	453.1
Accounts Payable	38.6	20.8	21.0	14.8	12.9
Accrued Expenses	14.0	18.4	18.1	9.3	11.7
Notes Payable/Short Term Debt	0.0	0.0	0.0	0.0	0.0
Current Portion - Long Term Debt/Capital Leases	-	-	-	0.5	1.1
Income Taxes Payable	16.3	1.2	3.7	1.8	0.6
Other Current Liabilities	6.1	4.5	3.9	3.3	1.5
Other Current liabilities, Total	22.3	5.8	7.6	5.1	2.2
Total Current Liabilities	74.9	45.0	46.7	29.7	27.9
Total Long Term Debt	0.0	0.0	0.0	0.0	0.0
Total Debt	0.0	0.0	0.0	0.5	1.1
Deferred Income Tax - LT Liability	0.2	0.2	10.2	6.9	5.5
Deferred Income Tax	0.2	0.2	10.2	6.9	5.5
Other Long Term Liabilities	16.8	18.2	18.2	11.5	10.8
Other Liabilities, Total	16.8	18.2	18.2	11.5	10.8
Total Liabilities	91.9	63.4	75.2	48.1	44.2
Convertible Preferred Stock - Non Redeemable	0.0	0.0	-	-	-
Preferred Stock - Non Redeemable, Net	0.0	0.0	-	-	-
Common Stock	0.4	0.4	0.4	0.4	0.4
Common Stock	0.4	0.4	0.4	0.4	0.4
Additional Paid-In Capital	457.7	444.6	435.8	426.4	421.0
Retained Earnings (Accumulated Deficit)	270.7	228.4	248.4	208.9	214.3
Treasury Stock - Common	-237.2	-231.2	-230.3	-227.7	-227.1
Unrealized Gain (Loss)	9.3	7.0	-	-	-
Translation Adjustment	6.3	1.1	-	-	-
Other Comprehensive Income	-	-	4.0	3.4	0.3
Other Equity, Total	6.3	1.1	4.0	3.4	0.3
Total Equity	507.3	450.3	458.4	411.5	408.9
Total Liabilities & Shareholders’ Equity	599.2	513.7	533.6	459.6	453.1
Shares Outstanding - Common Stock Primary Issue	32.0	31.7	31.5	31.4	31.3
Total Common Shares Outstanding	32.0	31.7	31.5	31.4	31.3
Treasury Shares - Common Stock Primary Issue	8.5	8.2	8.1	8.0	7.9
Employees	817	-	773	693	761
Number of Common Shareholders	148	-	157	159	163
Accumulated Goodwill Amortization Suppl.	0.0	-	0.0	0.0	0.0
Accumulated Intangible Amort, Suppl.	30.8	26.0	22.3	24.3	19.8
Total Capital Leases, Supplemental	0.2	-	0.1	0.1	0.2
Capital Lease Payments Due in Year 1	0.0	-	0.0	0.1	0.1
Capital Lease Payments Due in Year 2	0.0	-	0.0	0.0	0.0
Capital Lease Payments Due in Year 3	0.0	-	0.0	0.0	0.0
Capital Lease Payments Due in Year 4	0.0	-	0.0	0.0	0.0
Capital Lease Payments Due in Year 5	0.0	-	0.0	0.0	0.0
Capital Lease Payments Due in 2-3 Years	0.1	-	0.0	0.0	0.1
Capital Lease Payments Due in 4-5 Years	0.0	-	0.0	0.0	0.0
Cap. Lease Pymts. Due in Year 6 & Beyond	0.0	-	0.0	0.0	-
Total Operating Leases, Supplemental	13.3	-	15.6	8.3	8.4
Operating Lease Payments Due in Year 1	3.6	-	3.9	3.8	3.6
Operating Lease Payments Due in Year 2	2.3	-	3.7	3.1	2.3
Operating Lease Payments Due in Year 3	2.1	-	1.5	1.0	1.7
Operating Lease Payments Due in Year 4	1.7	-	1.0	0.3	0.6
Operating Lease Payments Due in Year 5	0.6	-	1.9	0.0	0.3
Operating Lease Pymts. Due in 2-3 Years	4.4	-	5.1	4.1	4.0
Operating Lease Pymts. Due in 4-5 Years	2.3	-	2.9	0.3	0.8
Oper. Lse. Pymts. Due in Year 6 & Beyond	3.1	-	3.7	0.0	0.0

Annual Cash Flows

Financials in: USD (mil)

	31-Dec-2012	31-Dec-2011	31-Dec-2010	31-Dec-2009	31-Dec-2008
Period Length	12 Months	12 Months	12 Months	12 Months	12 Months
UpdateType/Date	Updated Normal 31-Dec-2012	Reclassified Normal 31-Dec-2012	Reclassified Normal 31-Dec-2012	Updated Normal 31-Dec-2009	Updated Normal 31-Dec-2008
Filed Currency	USD	USD	USD	USD	USD
Exchange Rate (Period Average)	1	1	1	1	1
Auditor	Ernst & Young LLP	Ernst & Young LLP	Ernst & Young LLP	Ernst & Young LLP	Ernst & Young LLP
Auditor Opinion	Unqualified	Unqualified	Unqualified	Unqualified	Unqualified
Net Income/Starting Line	42.3	-20.0	39.5	-6.7	33.3
Depreciation	27.6	27.2	26.7	26.8	24.1
Depreciation/Depletion	27.6	27.2	26.7	26.8	24.1
Deferred Taxes	3.0	-29.4	4.6	-1.9	2.0
Unusual Items	-1.9	-0.4	-5.4	9.8	1.6
Equity in Net Earnings (Loss)	-	-	-	1.2	0.6
Other Non-Cash Items	7.6	9.9	6.6	8.9	8.6
Non-Cash Items	5.7	9.5	1.3	19.9	10.9
Accounts Receivable	-9.2	4.0	-9.0	-2.8	20.6
Inventories	-14.9	-12.4	-9.2	0.4	-9.5
Other Assets	4.0	-8.2	-4.7	-3.8	2.6
Accounts Payable	17.2	-0.2	5.2	1.8	-8.7
Accrued Expenses	15.2	-1.4	11.6	-2.4	-7.8
Taxes Payable	-	-	-	-5.0	-5.8
Other Liabilities	-	-	-	2.4	-1.2
Changes in Working Capital	12.3	-18.2	-6.1	-9.4	-9.8
Cash from Operating Activities	91.0	-31.0	66.0	28.8	60.6
Purchase of Fixed Assets	-29.3	-20.7	-16.2	-17.3	-50.6
Purchase/Acquisition of Intangibles	0.0	-10.4	0.0	0.0	-
Capital Expenditures	-29.3	-31.1	-16.2	-17.3	-50.6
Acquisition of Business	0.0	0.0	-3.9	0.0	-33.1
Sale of Fixed Assets	-	-	-	0.0	0.0
Sale/Maturity of Investment	106.5	121.8	65.6	65.2	85.9
Purchase of Investments	-118.3	-93.2	-104.4	-66.5	-54.9
Other Investing Cash Flow	0.1	0.1	0.1	0.0	-
Other Investing Cash Flow Items, Total	-11.6	28.6	-42.6	-1.3	-2.0
Cash from Investing Activities	-41.0	-2.5	-58.8	-18.6	-52.7
Other Financing Cash Flow	0.5	0.0	-2.9	0.0	-0.1
Financing Cash Flow Items	0.5	0.0	-2.9	0.0	-0.1
Repurchase/Retirement of Common	-6.0	-0.9	-2.6	-0.6	-59.2
Common Stock, Net	-6.0	-0.9	-2.6	-0.6	-59.2
Options Exercised	4.6	1.3	1.8	0.2	1.6
Issuance (Retirement) of Stock, Net	-1.4	0.4	-0.8	-0.3	-57.6
Short Term Debt Issued	-	-	-	5.7	13.9
Short Term Debt Reduction	-	-	-	-6.3	-12.8
Short Term Debt, Net	-	-	-	-0.6	1.1
Issuance (Retirement) of Debt, Net	-	-	-	-0.6	1.1
Cash from Financing Activities	-0.8	0.4	-3.7	-1.0	-56.5
Foreign Exchange Effects	2.4	-1.1	0.4	0.9	-1.6
Net Change in Cash	51.5	-34.1	3.9	10.1	-50.2
Net Cash - Beginning Balance	34.5	68.6	64.7	54.6	104.8
Net Cash - Ending Balance	86.1	34.5	68.6	64.7	54.6
Cash Interest Paid	0.1	0.0	0.1	0.2	0.2
Cash Taxes Paid	5.7	11.3	12.2	1.6	14.1

 Annual Income Statement

	31-Dec-2012	31-Dec-2011	31-Dec-2010	31-Dec-2009	31-Dec-2008
Period Length	12 Months	12 Months	12 Months	12 Months	12 Months
UpdateType/Date	Updated Normal 31-Dec-2012	Updated Normal 31-Dec-2011	Updated Normal 31-Dec-2010	Updated Normal 31-Dec-2009	Updated Normal 31-Dec-2008
Filed Currency	USD	USD	USD	USD	USD
Exchange Rate (Period Average)	1	1	1	1	1
Auditor	Ernst & Young LLP	Ernst & Young LLP	Ernst & Young LLP	Ernst & Young LLP	Ernst & Young LLP
Auditor Opinion	Unqualified	Unqualified	Unqualified	Unqualified	Unqualified
Revenues	407.4	390.1	367.3	254.7	339.1
Total Revenue	407.4	390.1	367.3	254.7	339.1
Depreciation in R&D	8.2	-	-	-	-
Depreciation in SGA	4.2	-	-	-	-
Amortization in R&D	0.1	-	-	-	-
Amortization in SGA	4.3	-	-	-	-
Contingent considerations	-2.7	-	-	-	-
Stock-based Compensation in SGA	7.3	-	-	-	-
Selling general administrative	72.0	-	-	-	-
Depreciation/Amortization in COR/COGS	10.5	-	-	-	-
Amortization in COR/COGS	0.3	-	-	-	-
Stock-based Compensation in COR/COGS	0.3	-	-	-	-
Other Cost of Revenue	195.4	-	-	-	-
Cost of Revenue	-	206.0	191.2	152.5	172.6
Other Research and development	46.8	-	-	-	-
Research/Development	-	53.7	48.6	37.2	37.8
Severance charges	1.6	-	-	-	-
Contract termination	0.0	84.6	0.0	0.0	-
Selling, general, and administrative	-	83.2	83.2	73.3	88.8
Asset Impairments	-	0.3	2.2	2.5	-
Severance	-	-	-	0.6	-
Impairment of Investments	0.0	0.8	0.0	2.5	3.4
Total Operating Expense	348.4	428.6	325.3	268.5	302.6
G/L on Invest. HFS, Maturity & Trading	-0.5	-	-	-	-
Interest Income	1.3	1.2	0.9	1.2	3.1
Interest Expense	-	-	-	0.0	-0.2
Other Other income (expense), net)	0.3	-	-	-	-
Other income (expense), net	-	-1.8	7.7	-1.0	0.7
Net Income Before Taxes	60.1	-39.1	50.6	-13.7	40.1
Provision for Income Taxes	17.8	-19.1	11.1	-7.0	6.8
Net Income After Taxes	42.3	-20.0	39.5	-6.7	33.3
Net Income Before Extra. Items	42.3	-20.0	39.5	-6.7	33.3
Net Income	42.3	-20.0	39.5	-6.7	33.3
Income Available to Com Excl ExtraOrd	42.3	-20.0	39.5	-6.7	33.3
Income Available to Com Incl ExtraOrd	42.3	-20.0	39.5	-6.7	33.3
Basic Weighted Average Shares	31.9	31.7	31.4	31.4	32.1
Basic EPS Excluding ExtraOrdinary Items	1.33	-0.63	1.26	-0.21	1.04
Basic EPS Including ExtraOrdinary Items	1.33	-0.63	1.26	-0.21	1.04
Dilution Adjustment	-	0.0	-	0.0	-
Diluted Net Income	42.3	-20.0	39.5	-6.7	33.3
Diluted Weighted Average Shares	32.7	31.7	31.9	31.4	32.1
Diluted EPS Excluding ExtraOrd Items	1.30	-0.63	1.24	-0.21	1.04
Diluted EPS Including ExtraOrd Items	1.30	-0.63	1.24	-0.21	1.04
DPS-Ordinary Shares	0.00	0.00	0.00	0.00	0.00
Gross Dividends - Common Stock	0.0	0.0	0.0	0.0	0.0
Normalized Income Before Taxes	61.7	46.5	52.8	-8.1	43.6
Inc Tax Ex Impact of Sp Items	18.3	10.9	11.6	-5.0	7.4
Normalized Income After Taxes	43.5	35.7	41.2	-3.0	36.2
Normalized Inc. Avail to Com.	43.5	35.7	41.2	-3.0	36.2
Basic Normalized EPS	1.36	1.12	1.31	-0.10	1.13
Diluted Normalized EPS	1.33	1.12	1.29	-0.10	1.13
Depreciation in R&D	8.2	-	-	-	-
Amortization in R&D	0.1	-	-	-	-
Research & Development Exp	46.8	53.7	48.6	37.2	37.8
Interest Expense	-	-	-	0.0	0.2
Amort of Intangibles	4.7	3.8	4.0	4.5	4.1
Rental Expense	3.8	3.7	3.4	4.3	3.6
BC - Depreciation of Fixed Assets	27.6	-	-	-	-
Depreciation	-	23.3	22.8	22.3	20.1
Current Tax - Federal	12.7	-	-	-	-
Current tax Domestic	-	7.3	4.1	-7.3	2.4
Current Tax - Local	0.4	-	-	-	-
Current tax Local	-	0.3	0.1	0.1	1.6
Current Tax - Foreign	1.7	-	-	-	-
Current tax Foreign	-	2.7	2.3	2.2	0.8
Current Tax - Total	14.7	10.3	6.5	-5.1	4.8
Deferred Tax - Federal	2.6	-	-	-	-
Deferred Tax Domestic	-	-27.0	4.2	-0.1	3.3
Deferred Tax - Local	0.4	-	-	-	-
Deferred Tax Local	-	-2.1	0.7	-0.4	-1.1
Deferred Tax - Foreign	0.0	-	-	-	-
Deferred Tax Foreign	-	-0.3	-0.3	-1.4	-0.1
Deferred Tax - Total	3.0	-29.4	4.6	-1.9	2.0
Income Tax - Total	17.8	-19.1	11.1	-7.0	6.8
401(k) Profit Sharing Plan	1.8	1.8	1.5	1.1	1.8
Total Pension Expense	1.8	1.8	1.5	1.1	1.8

Annual Balance Sheet

Financials in: USD (mil)

	31-Dec-2012	31-Dec-2011	31-Dec-2010	31-Dec-2009	31-Dec-2008
UpdateType/Date	Updated Normal 31-Dec-2012	Reclassified Normal 31-Dec-2012	Updated Normal 31-Dec-2010	Updated Normal 31-Dec-2009	Updated Normal 31-Dec-2008
Filed Currency	USD	USD	USD	USD	USD
Exchange Rate	1	1	1	1	1
Auditor	Ernst & Young LLP	Ernst & Young LLP	Ernst & Young LLP	Ernst & Young LLP	Ernst & Young LLP
Auditor Opinion	Unqualified	Unqualified	Unqualified	Unqualified	Unqualified
Cash and cash equivalents	86.1	34.5	68.6	64.7	54.6
Marketable securities, current portion	70.4	75.6	58.5	32.7	37.7
Accounts Rcvbl.	61.7	52.3	55.3	46.5	43.2
Doubtful Account	-0.9	-0.8	-0.8	-2.3	-1.0
Raw Materials	26.9	20.5	16.5	15.0	15.6
Work in Progress	2.1	1.7	2.1	2.4	1.2
Finished Goods	62.0	54.0	46.6	38.9	41.6
Excess & Obsolescence Reserve	-3.4	-2.6	-2.4	-2.6	-2.4
Deferred income taxes	4.5	4.4	6.8	8.0	6.9
Income taxes receivable	0.0	3.7	4.6	10.8	4.8
Other Current Assets(1)	9.0	13.3	12.7	-	-
Prepaid/Other	12.2	14.4	14.4	19.4	15.6
Total Current Assets	330.5	271.2	283.0	233.6	218.0
Land	1.2	1.1	1.1	1.1	1.1
Buildings	27.1	26.1	25.7	25.5	24.9
Machinery and Equipment	142.4	138.7	138.7	123.3	106.4
Software	26.0	25.0	28.3	37.3	35.5
Cylinders and canisters	57.7	50.5	43.5	37.2	34.7
Furniture and Fixtures	2.3	3.0	2.8	2.6	2.7
Leasehold Improvements	21.8	24.8	26.5	21.5	21.7
Construction in Progress	14.3	6.5	2.1	6.3	15.4
Accumulated Depreciation	-167.6	-159.4	-149.6	-130.1	-105.9
Deferred income taxes, non-current	15.1	19.1	2.1	2.7	1.6
Goodwill, Gross	46.8	-	-	-	-
Goodwill	-	46.5	47.0	33.4	33.4
Acc Amort Goodwill	0.0	-	-	-	-
Accumulated Amort	-	-	0.0	0.0	0.0
Other intangibles	-	-	51.3	47.5	47.0
Acc Amort patents & Trademarks	-29.0	-25.3	-	-	-
Acc Amort Other Intangibles	-1.8	-0.7	-	-	-
Amortization	-	-	-22.3	-24.3	-19.8
Other non-current assets	22.6	20.6	28.1	31.5	32.9
Marketable securities, non-current	12.1	3.3	25.4	10.6	3.7
Patents & Trademarks	66.5	49.4	-	-	-
Other	11.2	13.2	-	-	-
Total Assets	599.2	513.7	533.6	459.6	453.1
Accounts Payable	38.6	20.8	21.0	14.8	12.9
Accrued liabilities	8.0	7.9	5.9	4.8	5.3
Accrued Salaries	6.0	10.5	12.2	4.5	6.4
Loans and notes payable, current	-	-	-	0.5	1.1
Income taxes payable	16.3	1.2	3.7	1.8	0.6
Other current liabilities	6.1	4.5	3.9	3.3	1.5
Total Current Liabilities	74.9	45.0	46.7	29.7	27.9
Deferred income taxes, non-current	0.2	0.2	10.2	6.9	5.5
Other non-current liabilities	16.8	18.2	18.2	11.5	10.8
Total Liabilities	91.9	63.4	75.2	48.1	44.2
Currency Translation Adjustments	6.3	1.1	-	-	-
Preferred stock, par value $.01 per shar	0.0	0.0	-	-	-
Unrealized Gain/Loss on Investments	8.2	7.0	-	-	-
Unrealized Gain/Loss on Investment	1.1	0.0	-	-	-
Common Stock	0.4	0.4	0.4	0.4	0.4
Additional paid-in capital	457.7	444.6	435.8	426.4	421.0
Treasury Stock	-237.2	-231.2	-230.3	-227.7	-227.1
Retained earnings	270.7	228.4	248.4	208.9	214.3
Accumul. Other	-	-	4.0	3.4	0.3
Total Equity	507.3	450.3	458.4	411.5	408.9
Total Liabilities & Shareholders' Equity	599.2	513.7	533.6	459.6	453.1
S/O-Ordinary Shares	32.0	31.7	31.5	31.4	31.3
Total Common Shares Outstanding	32.0	31.7	31.5	31.4	31.3
T/S-Ordinary Shares	8.5	8.2	8.1	8.0	7.9
Amortization of Goodwill	0.0	-	0.0	0.0	0.0
Acc Amort patents & Trademarks	29.0	25.3	-	-	-
Acc Amort Other Intangibles	1.8	0.7	-	-	-
Amortization of Intangible	-	-	22.3	24.3	19.8
Full-Time Employees	817	-	773	693	761
Number of Common Shareholders	148	-	157	159	163
Capital Lease- Less Than 1 Year	0.0	-	0.0	0.1	0.1
Capital Lease- 1-3 Years	0.1	-	0.0	0.0	0.1
Capital Lease- 3-5 Years	0.0	-	0.0	0.0	0.0
Capital Lease- Thereafter	0.0	-	0.0	0.0	-
Total Capital Leases, Supplemental	0.2	-	0.1	0.1	0.2
Operating Lease Due Within 1 Year	3.6	-	3.9	3.8	3.6
Operating Lease Due Within 2 Years	2.3	-	3.7	3.1	2.3
Operating Lease Due Within 3 Years	2.1	-	1.5	1.0	1.7
Operating Lease Due Within 4 Years	1.7	-	1.0	0.3	0.6
Operating Lease Due Within 5 Years	0.6	-	1.9	0.0	0.3
Operating Lease - Remaining	3.1	-	3.7	-	0.0
Total Operating Leases, Supplemental	13.3	-	15.6	8.3	8.4

Annual Cash Flows

Financials in: USD (mil)

	31-Dec-2012	31-Dec-2011	31-Dec-2010	31-Dec-2009	31-Dec-2008
Period Length	12 Months	12 Months	12 Months	12 Months	12 Months
UpdateType/Date	Updated Normal 31-Dec-2012	Reclassified Normal 31-Dec-2012	Reclassified Normal 31-Dec-2012	Updated Normal 31-Dec-2009	Updated Normal 31-Dec-2008
Filed Currency	USD	USD	USD	USD	USD
Exchange Rate (Period Average)	1	1	1	1	1
Auditor	Ernst & Young LLP	Ernst & Young LLP	Ernst & Young LLP	Ernst & Young LLP	Ernst & Young LLP
Auditor Opinion	Unqualified	Unqualified	Unqualified	Unqualified	Unqualified
Net Income	42.3	-20.0	39.5	-6.7	33.3
Depreciation	27.6	27.2	26.7	26.8	24.1
Provision for bad debts	-	-	-	1.4	0.3
Provision for inventory obsolescence	1.9	1.0	0.6	2.1	1.5
Deferred income taxes	3.0	-29.4	4.6	-1.9	2.0
Non-cash royalty	-2.6	0.0	0.0	-	-
Tax Benefits Options	-	-	-	-0.6	0.3
Excess tax benefit from share-based paym	-	-	-	0.0	-0.2
Realized gain on sale of marketable secu	-	-	-	0.0	-2.0
Gain on remeasurement of contingent cons	-2.7	-1.7	0.0	0.0	-
Stock-based compensation expense	8.4	7.5	7.7	5.7	6.7
Long-lived asset impairments	0.8	0.6	0.5	7.3	0.2
Gain on remeasurement of non-controlling	0.0	0.0	-5.9	0.0	-
Impairment of investments	0.0	0.8	0.0	2.5	3.4
Loss from equity method investee	-	-	-	1.2	0.6
Other	-0.2	1.4	-1.7	0.3	0.0
Accounts Receivable	-9.2	4.0	-9.0	-2.8	20.6
Inventories	-14.9	-12.4	-9.2	0.4	-9.5
Other Assets	4.0	-8.2	-4.7	-3.8	2.6
Accounts Payable	17.2	-0.2	5.2	1.8	-8.7
Accrued expenses, income taxes and other	15.2	-1.4	11.6	-2.4	-7.8
Income Taxes	-	-	-	-5.0	-5.8
Other Liabilities	-	-	-	2.4	-1.2
Cash from Operating Activities	91.0	-31.0	66.0	28.8	60.6
Capital Expenditures	-29.3	-20.7	-16.2	-17.3	-50.6
Sale of Assets	-	-	-	0.0	0.0
Proceeds from sale of a cost basis inves	-	-	-	-	0.0
Acquisitions of assets and investments	-11.1	-6.7	-3.1	-	-
Intangible rights acquired due to contra	0.0	-10.4	0.0	0.0	-
Acquisitions, net of cash acquired	0.0	0.0	-3.9	0.0	-33.1
Acquisitions of cost-basis and equity-ba	-	-	-	0.0	-10.0
Purchases of marketable securities	-107.1	-86.4	-101.2	-66.5	-44.9
Proceeds from sale of cost and equity-ba	0.0	0.0	5.2	-	-
Proceeds from sales or maturities of mar	106.5	121.8	60.4	65.2	85.9
Other	0.1	0.1	0.1	0.0	-
Cash from Investing Activities	-41.0	-2.5	-58.8	-18.6	-52.7
Other	0.0	0.0	-2.9	0.0	-0.3
Purchases of treasury stock	-6.0	-0.9	-2.6	-0.6	-59.2
Credit line repayments	-	-	-	-6.3	-12.8
Credit line borrowings	-	-	-	5.7	13.9
Proceeds from exercise of stock options	4.6	1.3	1.8	0.2	1.6
Excess tax benefit from share-based paym	0.6	0.0	0.0	0.0	0.2
Cash from Financing Activities	-0.8	0.4	-3.7	-1.0	-56.5
Foreign Exchange Effects	2.4	-1.1	0.4	0.9	-1.6
Net Change in Cash	51.5	-34.1	3.9	10.1	-50.2
Net Cash - Beginning Balance	34.5	68.6	64.7	54.6	104.8
Net Cash - Ending Balance	86.1	34.5	68.6	64.7	54.6
Cash Interest Paid	0.1	0.0	0.1	0.2	0.2
Cash Taxes Paid	5.7	11.3	12.2	1.6	14.1

Financial Health

Key Indicators USD (mil)
Â	Quarter Ending 30-Jun-2013	Quarter Ending Yr Ago	Annual Year End 31-Dec-2012	1 Year Growth	3 Year Growth	5 Year Growth
Total Revenue (?)	102.0	-3.67%	407.4	4.45%	16.95%	2.28%
Research & Development (?)	13.1	-5.03%	46.8	-12.80%	8.01%	9.40%
Operating Income (?)	12.7	-24.92%	59.1	-	-	2.39%
Income Available to Common Excl Extraord Items (?)	9.4	-17.30%	42.3	-	-	0.87%
Basic EPS Excl Extraord Items (?)	0.30	-17.33%	1.33	-	-	2.79%
Capital Expenditures (?)	23.9	80.59%	29.3	-5.72%	19.20%	-3.62%
Cash from Operating Activities (?)	3.4	-89.24%	91.0	-	46.79%	6.97%
Free Cash Flow (?)	-20.5	-	61.6	-	75.29%	15.74%
Total Assets (?)	585.2	7.08%	599.2	16.64%	9.24%	4.01%
Total Liabilities (?)	74.7	-5.21%	91.9	45.02%	24.09%	9.69%
Total Long Term Debt (?)	0.0	-	0.0	-	-	-
Employees (?)	-	-	817	-	5.64%	0.20%
Total Common Shares Outstanding (?)	31.9	-0.12%	32.0	0.84%	0.63%	-0.72%
Market Cap (?)	754.5	14.84%	667.8	5.11%	4.54%	-8.99%

Key Ratios
Â	31-Dec-2012	31-Dec-2011	31-Dec-2010	31-Dec-2009	31-Dec-2008
Profitability
Gross Margin (?)	49.31%	47.20%	47.93%	40.12%	49.11%
Operating Margin (?)	14.50%	-9.87%	11.42%	-5.43%	10.76%
Pretax Margin (?)	14.76%	-10.03%	13.79%	-5.36%	11.84%
Net Profit Margin (?)	10.39%	-5.13%	10.76%	-2.61%	9.83%
Financial Strength
Current Ratio (?)	4.41	6.03	6.06	7.87	7.82
Long Term Debt/Equity (?)	0.00	0.00	0.00	0.00	0.00
Total Debt/Equity (?)	0.00	0.00	0.00	0.00	0.00
Management Effectiveness
Return on Assets (?)	7.61%	-3.82%	7.96%	-1.46%	7.05%
Return on Equity (?)	8.84%	-4.41%	9.08%	-1.62%	7.90%
Efficiency
Receivables Turnover (?)	7.02	6.82	6.43	4.99	6.19
Inventory Turnover (?)	2.56	3.02	3.28	2.78	3.29
Asset Turnover (?)	0.73	0.75	0.74	0.56	0.72

Market Valuation USD (mil)
P/E (TTM) (?)	20.34	.	Enterprise Value (?)	779.3
Price/Sales (TTM) (?)	2.18	.	Enterprise Value/Revenue (TTM) (?)	1.90
Price/Book (MRQ) (?)	1.75	.	Enterprise Value/EBITDA (TTM) (?)	8.59
Market Cap as of 18-Oct-2013 (?)	893.9	.

ratio

Traded: NASDAQ: ATMI	Financials in: USD (actual units)
Industry: Semiconductors	As of 18-Oct-2013
Sector: Technology

	Company	Industry	Sector	S&P 500
Valuation Ratios
P/E Excluding Extraordinary (TTM) (?)	20.34	19.99	22.09	19.68
P/E High Excluding Extraordinary - Last 5 Yrs (?)	16.11	36.86	42.91	32.79
P/E Low Excluding Extraordinary - Last 5 Yrs (?)	14.85	12.99	12.36	10.71
Beta (?)	1.25	1.28	1.19	1.00
Price/Revenue (TTM) (?)	2.18	3.44	4.07	2.57
Price/Book (MRQ) (?)	1.75	3.87	4.73	3.67
Price to Tangible Book (MRQ) (?)	2.13	4.36	6.85	5.21
Price to Cash Flow Per Share (TTM) (?)	11.95	15.83	17.48	14.22
Price to Free Cash Flow Per Share (TTM) (?)	38.89	26.54	23.00	26.26
Dividends
Dividend Yield (?)	-	2.44%	1.65%	2.26%
Dividend Per Share - 5 Yr Avg (?)	0.00	1.35	0.71	1.99
Dividend 5 Yr Growth (?)	-	21.22%	7.13%	0.08%
Payout Ratio (TTM) (?)	0.00%	18.90%	10.38%	25.98%
Growth Rates (%)
Revenue (MRQ) vs Qtr 1 Yr Ago (?)	-3.67%	32.22%	28.50%	15.58%
Revenue (TTM) vs TTM 1 Yr Ago (?)	6.92%	40.54%	18.25%	17.69%
Revenue 5 Yr Growth (?)	2.28%	11.04%	16.94%	8.97%
EPS (MRQ) vs Qtr 1 Yr Ago (?)	-17.06%	50.47%	41.24%	19.49%
EPS (TTM) vs TTM 1 Yr Ago (?)	278.36%	130.87%	49.53%	32.55%
EPS 5 Yr Growth (?)	2.33%	7.09%	20.44%	9.86%
Capital Spending 5 Yr Growth (?)	-3.62%	-26.65%	9.78%	-2.04%
Financial Strength
Quick Ratio (MRQ) (?)	3.72	3.02	1.98	1.24
Current Ratio (MRQ) (?)	5.29	3.90	2.38	1.79
LT Debt/Equity (MRQ) (?)	0.00	0.19	0.31	0.64
Total Debt/Equity (MRQ) (?)	0.00	0.21	0.36	0.73
Interest Coverage (TTM) (?)	-	11.34	11.30	13.80
Profitability Ratios (%)
Gross Margin (TTM) (?)	48.39%	54.52%	55.32%	45.21%
Gross Margin - 5 Yr Avg (?)	47.18%	49.69%	53.24%	44.91%
EBITD Margin (TTM) (?)	22.11%	27.82%	25.78%	24.43%
EBITD Margin - 5 Yr Avg (?)	18.24%	18.02%	21.39%	22.84%
Operating Margin (TTM) (?)	14.39%	24.80%	22.29%	20.63%
Operating Margin - 5 Yr Avg (?)	4.84%	13.57%	17.62%	18.28%
Pretax Margin (TTM) (?)	15.23%	24.89%	22.54%	17.95%
Pretax Margin - 5 Yr Avg (?)	5.58%	14.88%	18.75%	17.10%
Net Profit Margin (TTM) (?)	10.95%	19.30%	17.35%	13.65%
Net Profit Margin - 5 Yr Avg (?)	5.03%	10.91%	12.72%	12.10%
Effective Tax Rate (TTM) (?)	28.14%	21.71%	23.73%	28.45%
Effective Tax rate - 5 Yr Avg (?)	9.81%	23.58%	24.82%	29.92%
Management Effectiveness (%)
Return on Assets (TTM) (?)	7.94%	15.21%	12.89%	8.54%
Return on Assets - 5 Yr Avg (?)	3.53%	8.48%	10.70%	8.40%
Return on Investment (TTM) (?)	8.88%	15.22%	13.09%	7.90%
Return on Investment - 5 Yr Avg (?)	3.85%	8.60%	11.50%	8.27%
Return on Equity (TTM) (?)	9.18%	21.72%	25.23%	19.72%
Return on Equity - 5 Yr Avg (?)	4.02%	11.50%	21.05%	20.06%
Efficiency
Revenue/Employee (TTM) (?)	502,295.00	514,699.51	617,868.03	927,613.77
Net Income/Employee (TTM) (?)	54,979.19	106,063.20	132,630.14	116,121.92
Receivables Turnover (TTM) (?)	6.08	10.12	8.08	13.25
Inventory Turnover (TTM) (?)	2.40	5.67	19.61	14.53
Asset Turnover (TTM) (?)	0.73	0.82	0.75	0.93

 Annual Ratios

	31-Dec-2012	31-Dec-2011	31-Dec-2010	31-Dec-2009	31-Dec-2008
Financial Strength
Current Ratio (?)	4.41	6.03	6.06	7.87	7.82
Quick/Acid Test Ratio (?)	2.90	3.68	3.99	5.13	5.00
Working Capital (?)	255.6	226.2	236.3	203.9	190.1
Long Term Debt/Equity (?)	0.00	0.00	0.00	0.00	0.00
Total Debt/Equity (?)	0.00	0.00	0.00	0.00	0.00
Long Term Debt/Total Capital (?)	0.00	0.00	0.00	0.00	0.00
Total Debt/Total Capital (?)	0.00	0.00	0.00	0.00	0.00
Payout Ratio (?)	0.00%	0.00%	0.00%	0.00%	0.00%
Effective Tax Rate (?)	29.60%	-	21.97%	-	16.99%
Total Capital (?)	507.3	450.3	458.4	412.0	410.0
Efficiency
Asset Turnover (?)	0.73	0.75	0.74	0.56	0.72
Inventory Turnover (?)	2.56	3.02	3.28	2.78	3.29
Days In Inventory (?)	142.41	120.91	111.26	131.32	110.92
Receivables Turnover (?)	7.02	6.82	6.43	4.99	6.19
Days Receivables Outstanding (?)	52.00	53.54	56.74	73.16	58.98
Revenue/Employee (?)	498,694	-	475,105	367,538	445,549
Operating Income/Employee (?)	72,307	-	54,254	-19,947	47,950
EBITDA/Employee (?)	111,772	-	88,818	18,724	79,673
Profitability
Gross Margin (?)	49.31%	47.20%	47.93%	40.12%	49.11%
Operating Margin (?)	14.50%	-9.87%	11.42%	-5.43%	10.76%
EBITDA Margin (?)	22.41%	-2.90%	18.69%	5.09%	17.88%
EBIT Margin (?)	14.50%	-9.87%	11.42%	-5.43%	10.76%
Pretax Margin (?)	14.76%	-10.03%	13.79%	-5.36%	11.84%
Net Profit Margin (?)	10.39%	-5.13%	10.76%	-2.61%	9.83%
R&D Expense/Revenue (?)	11.49%	13.77%	13.25%	14.59%	11.15%
COGS/Revenue (?)	50.69%	52.80%	52.07%	59.88%	50.89%
SG&A Expense/Revenue (?)	19.47%	21.34%	22.66%	28.76%	26.18%
Management Effectiveness
Return on Assets (?)	7.61%	-3.82%	7.96%	-1.46%	7.05%
Return on Equity (?)	8.84%	-4.41%	9.08%	-1.62%	7.90%
Valuation
Free Cash Flow/Share (?)	1.93	-1.96	1.58	0.36	0.32
Operating Cash Flow/Share  (?)	2.84	-0.98	2.09	0.92	1.94

Current Market Multiples
Market Cap/Earnings (TTM) (?)	20.34
Market Cap/Equity (MRQ) (?)	1.75
Market Cap/Revenue (TTM) (?)	2.18
Market Cap/EBIT (TTM) (?)	14.69
Market Cap/EBITDA (TTM) (?)	9.85
Enterprise Value/Earnings (TTM) (?)	17.73
Enterprise Value/Equity (MRQ) (?)	1.53
Enterprise Value/Revenue (TTM) (?)	1.90
Enterprise Value/EBIT (TTM) (?)	12.81
Enterprise Value/EBITDA (TTM) (?)	8.59

Stock Report

Stock Snapshot

Traded: NASDAQ: ATMI

As of 18-Oct-2013    US Dollars

Recent Price	$28.02	EPS	$1.33
52 Week High	$28.41	Price/Sales	2.19
52 Week Low	$17.59	Price/Earnings	16.81
Avg. Volume (mil)	0.13	Price/Book	1.77
Market Value (mil)	$893.88	Beta	1.25

	Price % Change	Rel S&P 500%
4 Week	4.59%	2.52%
13 Week	3.39%	0.28%
52 Week	52.28%	27.22%
Year to Date	34.20%	9.71%

2 Year Weekly End Price & Volume

Tooltip

Tooltip

Stock History

Market Cap History
	30-Jun-13	% Chg	31-Mar-13	% Chg	31-Dec-12	% Chg	30-Sep-12	% Chg	30-Jun-12	% Chg
Total Common Shares Outstanding	32	-0.1	32	-0.2	32	-0.1	32	0.2	32	0.1
Market Cap	754.5	5.3	716.2	7.2	667.8	12.3	594.5	-9.5	657.0	-11.7

Yearly Price History
	2013	% Chg	2012	% Chg	2011	% Chg	2010	% Chg	2009	% Chg
High Price	28.41	13.4	25.05	16.6	21.48	-2.6	22.05	11.5	19.77	-39.2
Low Price	19.89	13.1	17.59	16.1	15.15	24.9	12.13	2.8	11.80	35.6
Year End Price	28.02	34.2	20.88	4.2	20.03	0.5	19.94	7.1	18.62	20.7

Monthly Price History
Price Ending Date	Open	High	Low	Close	Volume
18-Oct-13	26.53	28.41	25.88	28.02	1,782,727
30-Sep-13	24.93	26.93	24.31	26.52	1,962,384
30-Aug-13	24.99	25.26	24.02	24.55	2,239,407
31-Jul-13	23.66	27.53	23.55	24.85	4,620,551
28-Jun-13	23.91	24.67	23.34	23.65	2,615,847
31-May-13	21.67	23.97	21.04	23.87	2,866,167
30-Apr-13	22.33	22.62	20.36	21.75	3,742,965
28-Mar-13	21.68	23.33	21.46	22.43	2,964,323
28-Feb-13	20.56	22.29	19.89	21.90	2,946,406
31-Jan-13	21.36	21.54	20.00	20.41	3,593,321
31-Dec-12	20.01	21.00	19.31	20.88	1,974,246
30-Nov-12	19.81	20.48	17.81	19.92	2,046,478
31-Oct-12	18.75	20.38	17.59	19.75	1,967,317

Standard & Poor’s

United States of America Long-Term Rating Lowered To 'AA+' Due To Political Risks, Rising Debt Burden; Outlook Negative

Publication date: 05-Aug-2011 20:13:14 EST

---

· We have lowered our long-term sovereign credit rating on the United States of America to 'AA+' from 'AAA' and affirmed the 'A-1+' short-term rating.

· We have also removed both the short- and long-term ratings from CreditWatch negative.

· The downgrade reflects our opinion that the fiscal consolidation plan that Congress and the Administration recently agreed to falls short of what, in our view, would be necessary to stabilize the government's medium-term debt dynamics.

· More broadly, the downgrade reflects our view that the effectiveness, stability, and predictability of American policymaking and political institutions have weakened at a time of ongoing fiscal and economic challenges to a degree more than we envisioned when we assigned a negative outlook to the rating on April 18, 2011.

· Since then, we have changed our view of the difficulties in bridging the gulf between the political parties over fiscal policy, which makes us pessimistic about the capacity of Congress and the Administration to be able to leverage their agreement this week into a broader fiscal consolidation plan that stabilizes the government's debt dynamics any time soon.

· The outlook on the long-term rating is negative. We could lower the long-term rating to 'AA' within the next two years if we see that less reduction in spending than agreed to, higher interest rates, or new fiscal pressures during the period result in a higher general government debt trajectory than we currently assume in our base case.

TORONTO (Standard & Poor's) Aug. 5, 2011--Standard & Poor's Ratings Services said today that it lowered its long-term sovereign credit rating on the United States of America to 'AA+' from 'AAA'. Standard & Poor's also said that the outlook on the long-term rating is negative. At the same time, Standard & Poor's affirmed its 'A-1+' short-term rating on the U.S. In addition, Standard & Poor's removed both ratings from CreditWatch, where they were placed on July 14, 2011, with negative implications.

The transfer and convertibility (T&C) assessment of the U.S.--our assessment of the likelihood of official interference in the ability of U.S.-based public- and private-sector issuers to secure foreign exchange for

debt service--remains 'AAA'.

We lowered our long-term rating on the U.S. because we believe that the prolonged controversy over raising the statutory debt ceiling and the related fiscal policy debate indicate that further near-term progress containing the growth in public spending, especially on entitlements, or on reaching an agreement on raising revenues is less likely than we previously assumed and will remain a contentious and fitful process. We also believe that the fiscal consolidation plan that Congress and the Administration agreed to this week falls short of the amount that we believe is necessary to stabilize the general government debt burden by the middle of the decade.

Our lowering of the rating was prompted by our view on the rising public debt burden and our perception of greater policymaking uncertainty, consistent with our criteria (see "Sovereign Government Rating Methodology and Assumptions ," June 30, 2011, especially Paragraphs 36-41). Nevertheless, we view the U.S. federal government's other economic, external, and monetary credit attributes, which form the basis for the sovereign rating, as broadly unchanged.

We have taken the ratings off CreditWatch because the Aug. 2 passage of the Budget Control Act Amendment of 2011 has removed any perceived immediate threat of payment default posed by delays to raising the government's debt ceiling. In addition, we believe that the act provides sufficient clarity to allow us to evaluate the likely course of U.S. fiscal policy for the next few years.

The political brinksmanship of recent months highlights what we see as America's governance and policymaking becoming less stable, less effective, and less predictable than what we previously believed. The statutory debt ceiling and the threat of default have become political bargaining chips in the debate over fiscal policy. Despite this year's wide-ranging debate, in our view, the differences between political parties have proven to be extraordinarily difficult to bridge, and, as we see it, the resulting agreement fell well short of the comprehensive fiscal consolidation program that some proponents had envisaged until quite recently. Republicans and Democrats have only been able to agree to relatively modest savings on discretionary spending while delegating to the Select Committee decisions on more comprehensive measures. It appears that for now, new revenues have dropped down on the menu of policy options. In addition, the plan envisions only minor policy changes on Medicare and little change in other entitlements,

the containment of which we and most other independent observers regard as key to long-term fiscal sustainability.

Our opinion is that elected officials remain wary of tackling the structural issues required to effectively address the rising U.S. public debt burden in a manner consistent with a 'AAA' rating and with 'AAA' rated sovereign peers (see Sovereign Government Rating Methodology and Assumptions," June 30, 2011, especially Paragraphs 36-41). In our view, the difficulty in framing a consensus on fiscal policy weakens the government's ability to manage public finances and diverts attention from the debate over how to achieve more balanced and dynamic economic growth in an era of fiscal stringency and private-sector deleveraging (ibid). A new political consensus might (or might not) emerge after the 2012 elections, but we believe that by then, the government debt burden will likely be higher, the needed medium-term fiscal adjustment potentially greater, and the inflection point on the U.S. population's demographics and other age-related spending drivers closer at hand (see "Global Aging 2011: In The U.S., Going Gray Will Likely Cost Even More Green, Now," June 21, 2011).

Standard & Poor's takes no position on the mix of spending and revenue measures that Congress and the Administration might conclude is appropriate for putting the U.S.'s finances on a sustainable footing.

The act calls for as much as $2.4 trillion of reductions in expenditure growth over the 10 years through 2021. These cuts will be implemented in two steps: the $917 billion agreed to initially, followed by an additional $1.5 trillion that the newly formed Congressional Joint Select Committee on Deficit Reduction is supposed to recommend by November 2011. The act contains no measures to raise taxes or otherwise enhance revenues, though the committee could recommend them.

The act further provides that if Congress does not enact the committee's recommendations, cuts of $1.2 trillion will be implemented over the same time period. The reductions would mainly affect outlays for civilian discretionary spending, defense, and Medicare. We understand that this fall-back mechanism is designed to encourage Congress to embrace a more balanced mix of expenditure savings, as the committee might recommend.

We note that in a letter to Congress on Aug. 1, 2011, the Congressional Budget Office (CBO) estimated total budgetary savings under the act to be at least $2.1 trillion over the next 10 years relative to its baseline assumptions. In updating our own fiscal projections, with certain modifications outlined below, we have relied on the CBO's latest "Alternate Fiscal Scenario" of June 2011, updated to include the CBO assumptions contained in its Aug. 1 letter to Congress. In general, the CBO's "Alternate Fiscal Scenario" assumes a continuation of recent Congressional action overriding existing law.

We view the act's measures as a step toward fiscal consolidation. However, this is within the framework of a legislative mechanism that leaves open the details of what is finally agreed to until the end of 2011, and Congress and the Administration could modify any agreement in the future. Even assuming that at least $2.1 trillion of the spending reductions the act envisages are implemented, we maintain our view that the U.S. net general government debt burden (all levels of government combined, excluding liquid financial assets) will likely continue to grow. Under our revised base case fiscal scenario--which we consider to be consistent with a 'AA+' long-term rating and a negative outlook--we now project that net general government debt would rise from an estimated 74% of GDP by the end of 2011 to 79% in 2015 and 85% by 2021. Even the projected 2015 ratio of sovereign indebtedness is high in relation to those of peer credits and, as noted, would continue to rise under the act's revised policy settings.

Compared with previous projections, our revised base case scenario now assumes that the 2001 and 2003 tax cuts, due to expire by the end of 2012, remain in place. We have changed our assumption on this because the majority of Republicans in Congress continue to resist any measure that would raise revenues, a position we believe Congress reinforced by passing the act. Key macroeconomic assumptions in the base case scenario include trend real GDP growth of 3% and consumer price inflation near 2% annually over the decade.

Our revised upside scenario--which, other things being equal, we view as consistent with the outlook on the 'AA+' long-term rating being revised to stable--retains these same macroeconomic assumptions. In addition, it incorporates $950 billion of new revenues on the assumption that the 2001 and 2003 tax cuts for high earners lapse from 2013 onwards, as the Administration is advocating. In this scenario, we project that the net general government debt would rise from an estimated 74% of GDP by the end of 2011 to 77% in 2015 and to 78% by 2021.

Our revised downside scenario--which, other things being equal, we view as being consistent with a possible further downgrade to a 'AA' long-term rating--features less-favorable macroeconomic assumptions, as outlined below and also assumes that the second round of spending cuts (at least $1.2 trillion) that the act calls for does not occur. This scenario also assumes somewhat higher nominal interest rates for U.S. Treasuries. We still believe that the role of the U.S. dollar as the key reserve currency confers a government funding advantage, one that could change only slowly over time, and that Fed policy might lean toward continued loose monetary policy at a time of fiscal tightening. Nonetheless, it is possible that interest rates could rise if investors re-price relative risks. As a result, our alternate scenario factors in a 50 basis point (bp)-75 bp rise in 10-year bond yields relative to the base and upside cases from 2013 onwards. In this scenario, we project the net public debt burden would rise from 74% of GDP in 2011 to 90% in 2015 and to 101% by 2021.

Our revised scenarios also take into account the significant negative revisions to historical GDP data that the Bureau of Economic Analysis announced on July 29. From our perspective, the effect of these revisions underscores two related points when evaluating the likely debt trajectory of the U.S. government. First, the revisions show that the recent recession was deeper than previously assumed, so the GDP this year is lower than previously thought in both nominal and real terms. Consequently, the debt burden is slightly higher. Second, the revised data highlight the sub-par path of the current economic recovery when compared with rebounds following previous post-war recessions. We believe the sluggish pace of the current economic recovery could be consistent with the experiences of countries that have had financial crises in which the slow process of debt deleveraging in the private sector leads to a persistent drag on demand. As a result, our downside case scenario assumes relatively modest real trend GDP growth of 2.5% and inflation of near 1.5% annually going forward.

When comparing the U.S. to sovereigns with 'AAA' long-term ratings that we view as relevant peers--Canada, France, Germany, and the U.K.--we also observe, based on our base case scenarios for each, that the trajectory of the U.S.'s net public debt is diverging from the others. Including the U.S., we estimate that these five sovereigns will have net general government debt to GDP ratios this year ranging from 34% (Canada) to 80% (the U.K.), with the U.S. debt burden at 74%. By 2015, we project that their net public debt to GDP ratios will range between 30% (lowest, Canada) and 83% (highest, France), with the U.S. debt burden at 79%. However, in contrast with the U.S., we project that the net public debt burdens of these other sovereigns will begin to decline, either before or by 2015.

Standard & Poor's transfer T&C assessment of the U.S. remains 'AAA'. Our T&C assessment reflects our view of the likelihood of the sovereign restricting other public and private issuers' access to foreign exchange needed to meet debt service. Although in our view the credit standing of the U.S. government has deteriorated modestly, we see little indication that official interference of this kind is entering onto the policy agenda of either Congress or the Administration. Consequently, we continue to view this risk as being highly remote.

The outlook on the long-term rating is negative. As our downside alternate fiscal scenario illustrates, a higher public debt trajectory than we currently assume could lead us to lower the long-term rating again. On the other hand, as our upside scenario highlights, if the recommendations of the Congressional Joint Select Committee on Deficit Reduction--independently or coupled with other initiatives, such as the lapsing of the 2001 and 2003 tax cuts for high earners--lead to fiscal consolidation measures beyond the minimum mandated, and we believe they are likely to slow the deterioration of the government's debt dynamics, the long-term rating could stabilize at 'AA+'.

FOREIGN EXCHANGE RATES

Currency	Unit	Indian Rupees
US Dollar	1	Rs.62.73
UK Pound	1	Rs.100.92
Euro	1	Rs.84.06

INFORMATION DETAILS

Report Prepared by :

NIS

RATING EXPLANATIONS

RATING		STATUS	PROPOSED CREDIT LINE
>86	Aaa	Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums	Unlimited
71-85	Aa	Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums	Large
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory
26-40	B	Capability to overcome financial difficulties seems comparatively below average.	Small
11-25	Ca	Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity	Limited with full security
<10	C	Absolute credit risk exists. Caution needed to be exercised	Credit not recommended
--	NB	New Business	--

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

Financial condition (40%) Ownership background (20%) Payment record (10%)

Credit history (10%) Market trend (10%) Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.